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CHAPTER I 
 
INTRODUCTION 
 
The eukaryotic cell division cycle 
 In order for multicellular organisms to fully develop, they must precisely undergo many 
rounds of cell division. The process of cell division involves the duplication and accurate 
segregation of the genetic material to two daughter cells. Research over the past 30 years from a 
number of model systems has illuminated both the complex nature and the strict conservation 
involved in cell cycle control. Although many of the key regulators have been identified through 
genetic and biochemical studies, the precise coordination among the regulators still remains 
relatively obscure. Cell division is fundamental for life, and inaccuracies in the transmission of 
genetic material to the progeny are a hallmark of many forms of cancer as well as many 
developmental disorders. Therefore, a more complete understanding of the events that regulate 
the cell division cycle will provide us with information pertinent to a fundamental biological 
process, as well as potential therapeutic tools with which to fight these processes in the event 
they go awry. 
The basic somatic cell division cycle of eukaryotes involves alternating rounds of DNA 
replication followed by segregation of the duplicated sister chromatids to opposite poles of the 
cell prior to cell cleavage (Figure 1). These events occur during DNA Synthesis phase (S phase) 
and Mitosis (M phase), respectively, just two of the four major cell cycle transitions found in 
eukaryotes. During S phase, the entire cellular genome is replicated error-free, and a linkage is 
established between the newly duplicated sister chromatids. Mitosis is coincident with 
dissolution of this linkage and the segregation of these sisters during anaphase. Cytokinesis is the 
final event of the cell cycle and results in cell cleavage to produce two identical daughter cells. 
Two intervening gap phases, G1 and G2, separate S and M phases. While most of the real labor of 
the cell cycle is accomplished during S and M phases, the two gap phases are responsible for 
most of the cellular growth as well as for monitoring the success and fidelity of previous cell 
cycle events. This success is monitored by checkpoints, which act as molecular stop signals to 
prevent transitions into subsequent cell cycle phases when the conditions are not right to do so.  
 
SM
G1G2
Figure 1. The eukaryotic cell division cycle. The somatic cell cycle is divided into four distinct phases:
G1, S, G2, and M. During the G1/S transition, the centrosome (black circle) is duplicated but remains
linked. During S phase, each chromatid is precisely replicated and a linkage is established that ties
the sister chromatids together. Upon progression through mitosis, this linkage is broken and the sister
chromatids separate to opposite poles of the cell. Cytokinesis produces two identical daughter cells as
the membrane is cleaved between the segregated sister chromatids.   
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These restraints inhibit the activities of a conserved family of protein kinases, the Cyclin-
dependent kinases (Cdks) that act at the center stage of the eukaryotic cell cycle.  
Cdks are highly conserved across the eukaryotic lineage from yeast to humans. As their 
name implies, this family of kinases is defined by its requirement for association with a cyclin 
subunit, an event necessary for its catalytic activity and substrate targeting. Cyclin subunits are 
characterized by their cell cycle periodicity as they are synthesized and destroyed during each 
cell cycle (Murray and Kirschner, 1989), and therefore, play a large role in the irreversibility of 
many aspects of cell cycle progression. The Cdk complex phosphorylates a number of critical 
substrates necessary for transition through different cell cycle phases, and Cdk activity rises and 
falls as the phase controlled is traversed. A team of Cdks and cyclins exist in higher eukaryotes 
that collaborate to drive distinct and sometimes overlapping cell cycle events by targeting 
different substrates (reviewed by Morgan, 1997). Cdks not only are responsible for driving the 
cell cycle through these major transitions, they also play a critical role in ensuring that certain 
events occur only once per cell cycle.  
 
Cdk1p and Its Regulation 
A rise in the activity of one Cdk, the Cdk1-Cyclin B complex (hereafter referred to as 
Cdk1p), is required for entry into mitosis in all eukaryotes. This activity was first described as 
Maturation Promoting Factor (MPF), a biochemical activity capable of driving Xenopus eggs 
from an interphase to a mitotic state (Masui and Markert, 1971; Newport and Kirschner, 1984). 
Genetic screens in unicellular eukaryotes like Schizosaccharomyces pombe and Saccharomyces 
cerevisiae aimed at identifying critical regulators of the cell cycle identified homologous genes 
required for traversing both the G1/S and G2/M transitions (Nurse and Bissett, 1981). These 
genes encode the protein kinase constituent of MPF (Gautier et al., 1988). Strong conservation 
among cell cycle regulators was readily apparent from experiments that demonstrated that the 
human cdk1+ gene could rescue the temperature sensitive lethality of the S. pombe cdk1- mutant 
(Lee and Nurse, 1987).  
Cdk1p activity peaks at the G2/M transition and falls precipitously after sister chromatid 
separation upon destruction of cyclin B. Such tight control over the activity of this complex 
suggests a complex mode(s) of regulation. Indeed, Cdk1p activity is not just regulated at the 
level of cyclin binding. Multiple highly conserved phosphorylation events impinge upon Cdk1p 
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during interphase to maintain its activity in check. These phosphorylations occur on conserved 
Thr and Tyr residues within the ATP binding pocket of the Cdk1p enzyme (Gould and Nurse, 
1989; Krek and Nigg, 1991) and preclude Cdk1p’s ability to bind ATP and thus function as a 
protein kinase. At the G2/M transition, these inhibitory phosphorylation events are removed from 
Cdk1p, and mitotic entry is initiated. As Cdk1p accumulates in late G2 in the phosphorylated 
state, the removal of these phosphorylation events acts as a rate-limiting step in the activation of 
Cdk1p. 
 
Identification of Key Regulators of Cell Cycle Progression in S. pombe 
The biochemical regulation of Cdk1p during the G2/M transition was first predicted based 
on genetic studies in the fission yeast, S. pombe (Nurse and Bissett, 1981; Russell and Nurse, 
1986; Russell and Nurse, 1987; Gould and Nurse, 1989). In S. pombe, a single Cdk1p-cyclin B 
complex is capable of driving the entire cell cycle, and its activity rises and falls as cells progress 
through mitosis (Figure 2) (Fisher and Nurse, 1996). The wee1+ and cdc25+ gene products were 
first identified as dose dependent inhibitors and inducers of mitotic entry, respectively (Russell 
and Nurse, 1986; Russell and Nurse, 1987). Evidence that these two regulators functioned 
independently and antagonistically to one another, and that they converged at the level of Cdk1p 
phosphorylation, was gained from a number of genetic observations. First, whereas the single 
mutants are inviable at the restrictive temperature, double mutants between cdc25- and wee1- are 
viable (Russell and Nurse, 1987). Second, overexpression of Cdc25p in the absence of wee1- 
function is additive and leads to mitotic catastrophe (Russell and Nurse, 1986). Additionally, 
mutation of Tyr-15 of Cdk1p to a non-phosphorylatable Phe mimicks wee1∆ in its ability to 
drive premature mitotic commitment (Gould and Nurse, 1989). Biochemical evidence 
subsequently confirmed these genetic predictions with evidence that the Wee1 (and the closely 
related Myt1) family of tyrosine kinases were responsible for inhibitory phosphorylation events 
at Thr-14 and Tyr-15 (Lundgren et al., 1991; Parker et al., 1992; Mueller et al., 1995). 
Conversely, the Cdc25 family of protein phosphatases was shown to catalyze the reversal of 
these phosphorylation events (Kumagai and Dunphy, 1991; Gautier et al., 1991; Lee et al., 
1992).  
Although these predictions were made nearly 20 years ago, S. pombe continues to serve 
as an excellent model system for the study of the biochemical events that regulate the cell  
Cdk1
Cyclin B
P
Cdk1
Cyclin B
Cdk1
Cdc25
Wee1
Cdk1
Cyclin B
P
P
G2
M
G1 S
Cyclin B
Figure 2. Progression through the cell cycle in S. pombe. A) Schematic representation of
the S. pombe cell cycle. Cells grow by tip elongation at both ends and divide by medial fission 
at a precise cell size. Cdc25p and Wee1p coordinate cell cycle position with mitotic entry through
modulation of the Tyr-15 phosphorylation state of Cdk1p. Mitotic exit is achieved by destruction of 
cyclin B (Cdc13p). 
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division cycle. S. pombe as a model system combines facile genetics and biochemistry with the 
ability to infer cell cycle stage as a function of its cell size (Nurse, 1975). Additionally, S. pombe 
is an excellent system for the study of cytokinesis, as it divides through the use of a medially 
placed contractile ring similar to animal cells (reviewed by Feierbach and Chang, 2001). These 
combinations make it particularly appealing for the study of the events that regulate mitotic 
progression. 
 
Regulation of Wee1 and Cdc25 
The balance in activities between the inhibitory kinases and the activating phosphatases 
determines the timing of mitotic initiation (reviewed by O’Farrell, 2001). It is not surprising then 
that both sets of enzymes are under stringent regulation throughout the course of the cell cycle. 
Wee1 and Cdc25 are both targets of the DNA damage and replication checkpoints. These 
checkpoints prevent Cdk1p activation by sustaining Wee1 activity and either inactivating or 
destabilizing Cdc25 (reviewed by Raleigh and O'Connell, 2000; Donzelli and Draetta, 2003). 
This regulation is mediated through phosphorylation of checkpoint response sites present on 
Wee1 and Cdc25. Even in the absence of checkpoint activation, Wee1 and Myt1 activities far 
outweigh those of Cdc25 during interphase to maintain Cdk1p in the inhibited state (Figure 3A). 
Strikingly, the same checkpoint response sites are phosphorylated on Cdc25 (Human Ser-216, 
Xenopus Ser-287) during an unperturbed interphase by separate kinases not involved in 
checkpoint signaling, such as C-Tak1 in mammals (Peng et al., 1998), protein kinase A in 
Xenopus (Duckworth et al., 2002), and the stress activated kinase, Srk1p in S. pombe (Lopez-
Aviles et al., 2005). That different cell cycle inputs would use the same sensors reveals a 
remarkable conservation among cell cycle regulation. These phosphorylation events promote 
Wee1 and Cdc25 binding to 14-3-3 molecules (Lee et al., 2001; Kumagai et al., 1998; Lopez-
Girona et al., 1999; Peng et al., 1998). Surprisingly, 14-3-3 interactions with Wee1 or Cdc25 
result in dramatically different effects. Wee1 phosphorylation by Chk1 promotes 14-3-3 binding 
and enhances Wee1 ability to arrest cell division in response to damage (Lee et al., 2001). With 
regard to Cdc25, this protein-protein interaction plays two important inhibitory roles: first, it acts 
as a tether for Cdc25 to localize to the cytoplasm (presumably away from Cdk1p in the nucleus), 
and second, it prevents dephosphorylation of the phosphorylated response site (Margolis et al., 
2003). Disruption of this binary complex has been postulated to play a critical role in  
Figure 3. Mitotic initiation in eukaryotes involves a Cdk1p auto-amplification loop. A) During interphase,
Cdk1-cyclin B complex is maintained inactive due to inhibitory phosphorylations by elevated Wee1 
(Myt1 as well) activity. Cdc25 is unable to reverse these phosphorylations because of attenuated 
activity and interaction with 14-3-3 (not shown). Polo kinase (orange) remains inactive due to intra-
molecular interaction through its kinase domain (KD) and its Polo Box Domain (PBD). B) The balance is 
switched upon entry into mitosis as Cdc25 activity increases and activates Cdk1-cyclin B complex. 
Cdk1-cyclin B enters into a positive amplification loop whereby it phosphorylates and activates Cdc25
and phosphorylates and inactivates Wee1. These phosphorylation events relieve Polo auto-inhibition and
allow Polo to bind to and target Cdc25 for additional activation and Wee1 for additional inactivation. 
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determining the timing of mitosis. Accordingly, a mutant of Cdc25 that fails to interact with 14-
3-3 is a more potent activator of mitotic initiation (Margolis et al., 2003).  
In addition to these regulatory factors that maintain this balance in the interphase state, 
many additional elements impinge upon Cdc25 and Wee1 and Myt1 activities at the G2/M 
transition to promote mitotic initiation. Mitotic commitment is coincident with an attenuation of 
the inhibitory kinase activities and burst in activity of the activating phosphatases. Wee1 proteins 
are phosphorylated and inactivated upon entry into mitosis through multiple mechanisms 
involving a number of kinases (reviewed by Kellogg, 2003). The Nim1p/Cdr1p kinase in fission 
yeast targets the C-terminal catalytic domain of Wee1p for phosphorylation and attenuates the 
tyrosine kinase activity of the enzyme (Wu and Russell, 1993; Parker et al., 1993). A second 
mitotic specific phosphorylation has been described for Xenopus Wee1 (Mueller et al., 1995a). 
This phosphorylation also renders the kinase less active towards its physiological substrate 
(dephosphorylated Cdk1p) and involves phosphorylation in the N-terminal regulatory domain of 
XWee1 by Cdk1p. Similarly, the fission yeast Wee1p N-terminus is inhibitory to its in vivo 
function (Aligue et al., 1997; Tang et al., 1993). Additionally, human Wee1 becomes a target for 
protein degradation by the SCF ubiquitin ligase in response to mitotic phosphorylation events 
(Watanabe et al., 2004). Myt1 activity is also attenuated upon the transition into M phase 
(Mueller et al., 1995b; Inoue and Sagata, 2005). 
Cdc25 family members are similarly regulated at the post-translational level via 
phosphorylation upon entry into mitosis. In contrast to the inhibition witnessed with Wee1p and 
Myt1p family members, Cdc25 activity can be stimulated through mitotic phosphorylation. 
Mammals contain three different Cdc25 isoforms (A, B, and C), which differ in their regulation 
and cell cycle timing (reviewed by Donzelli and Draetta, 2003). Both hCdc25C and hCdc25A are 
mitotic phosphoproteins (Izumi et al., 1992; Hoffmann et al., 1993); however, this 
phosphorylation differs in its effects. hCdc25C catalytic activity is stimulated upon mitotic 
phosphorylation, whereas hCdc25A phosphorylation protects the protein from proteolysis and 
has no influence on activity (Mailand et al., 2000). S. pombe Cdc25p is also hyperphosphorylated 
and hyperactive at the G2/M transition (Kovelman and Russell, 1996). Similar to mitotic 
phosphorylation of hCdc25C and Xenopus Cdc25, elimination of this phosphorylation returns 
SpCdc25p activity to basal levels (Kovelman and Russell, 1996; Kumagai and Dunphy, 1992; 
Izumi et al., 1992). The mitotic phosphorylation and activation of Cdc25 proteins requires the 
 9 
activity of Cdk1p, and in vitro Cdk1p phosphorylation of hCdc25C and Xenopus Cdc25 
stimulates its activity (Hoffmann et al., 1993; Izumi and Maller, 1993). In vivo, Cdk2p catalyzes 
the removal of 14-3-3 from Xenopus Cdc25 through phosphorylation of its amino terminus 
(Margolis et al., 2003). Thus, an involvement for Cdk1p directly in the activation of Cdc25 (and 
inactivation of Wee1 and Myt1) has led to the proposal of an auto-amplification loop involving 
Cdk1p activation at mitotic onset (Figure 3B). This model has been used to explain why addition 
of small amounts of active Cdk1p leads to the creation of large amounts of active kinase 
complex, as well as to account for the rapid and irreversible entry of cells into the mitotic state 
(reviewed by O'Farrell, 2001). Cdk1p is also responsible for the phosphorylation-dependent 
stabilization of hCdc25A observed in mitosis (Mailand et al., 2002b). Adding to the complexity 
of this self-amplification loop is the finding that the conserved Polo family of protein kinases 
targets these G2/M regulators for additional levels of phosphorylation and activation/inactivation 
after prior phosphorylation by Cdk1p (Elia et al., 2003; Watanabe et al., 2004; Inoue and Sagata, 
2005).  
At exit from mitosis, the dephosphorylation of hCdc25A leads to its recognition and 
ubiquitination by the Anaphase-Promoting Complex/Cyclosome (APC/C) ubiquitin ligase 
(Mailand et al., 2002b). Although hCdc25C similarly is dephosphorylated at mitotic exit, this 
dephosphorylation does not affect its turnover, but rather returns its activity to basal levels 
(Mailand et al., 2002b). SpCdc25p has been predicted to be destabilized during late mitosis 
(Ducommun et al., 1990; Moreno et al., 1990), but it is unclear whether its stability is linked to 
its phosphorylation status. Additionally, in S. pombe the Cdc25p -14-3-3 interaction is resumed 
during late mitosis (Lopez-Girona et al., 1999). While Ser/Thr protein phosphatases (PPs), such 
as PP2A, have been predicted to reverse the activating phosphorylations on hCdc25C (Clarke et 
al., 1993), it is not known if PP2A accounts for all phosphatase activity counteracting activating 
phosphorylations of Cdc25 homologs during the exit from mitosis. 
 
Regulation of Mitotic Exit 
In addition to these G2/M regulators, Cdk1p phosphorylates a number of mitotic 
substrates essential for a coordinated progression through mitosis. Cdk1p activity must 
subsequently be attenuated in late mitosis to allow the exit from mitosis, a period where mitotic 
structures are disassembled and mitotic events are reversed, as well as for cytokinesis to occur 
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(Wheatley et al., 1997). Similar to the mitotic inhibition of Wee1 and Myt1, Cdk1p 
phosphorylates many of its inhibitors and attenuates their activities during mitotic progression. 
For instance, S. cerevisiae Cdk1p phosphorylates the Cdk1p inhibitor, Sic1p, which is then 
targeted for degradation by the SCF ubiquitin ligase (Verma et al., 1997). Cdk1p additionally 
phosphorylates the transcription factor for Sic1p, Swi5p, to prevent its accumulation in the 
nucleus (Moll et al., 1991). The signal that determines the degradation of Sic1p is exquisitely 
fine tuned to the amount of Cdk1p activity present in cells. Maximal Sic1p turnover requires 6 of 
the 9 potential phosphorylation sites to be occupied (Nash et al., 2001). During mitotic exit and 
subsequent reduction in Cdk1p activity, Sic1p is stabilized and further reduces Cdk1p activity.  
If high levels of Cdk1p activity inhibit its attenuation, then how is the mitotic state ever 
inactivated to allow for exit from mitosis? Somewhat anomalously, Cdk1p activity in mitosis has 
also been reported to initiate the signals that eventually destroy it. Destruction of mitotic cyclin B 
levels during anaphase drives Cdk1p inactivation at mitotic exit. This destruction is mediated by 
the ubiquitin system of protein degradation (reviewed by Hochstrasser, 1996). Cyclin B is 
modified by the addition of a poly-ubiquitin chain, which targets the protein to the proteasome to 
be degraded. The APC/C adds the poly-ubiquitin chain to cyclin B and other select molecules 
during anaphase and mitotic exit (reviewed by Morgan, 1999). The APC/C is activated at 
anaphase when complexed with specific activators capable of targeting the ubiquitin ligase to the 
correct substrates. One such activator, Cdc20/Fizzy, initiates anaphase by catalyzing the 
ubiquitination of the anaphase inhibitor, Securin, and cyclin B (Visintin et al., 1997; Lim et al., 
1998). Phosphorylations of APC/C components and Cdc20/Fizzy by Cdk1p stabilize the 
interaction (Rudner and Murray, 2000; Golan et al., 2002), and thus initiate anaphase progression 
and cyclin proteolysis. However, this model for APC/C activation may not be as simple as 
presented. Cdk1p activity is also required for maintenance of the spindle checkpoint 
(D'Angiolella et al., 2003), and high levels of Cdk1p also inhibit the activity of separase 
(Stemmann et al., 2001), a protease required for sister chromatid separation. It seems likely then 
that anaphase initiation and the exit from mitosis respond to different amounts of Cdk1p activity. 
Consistent with this, mitotic Cdk1p inactivation occurs in two phases in S. cerevisiae (Yeong et 
al., 2000). The first begins at the metaphase to anaphase transition and requires the activity of the 
APCCdc20 to attenuate Cdk1p activity. The second phase requires a separate APC/C complex 
involving the activator, Cdh1p/Hct1p, and culminates in complete abrogation of Cdk1p activity 
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at mitotic exit. During these phases, other elements may contribute to a reduction in Cdk1p 
activity. The Cdk1p auto-amplification loop is turned off at this time, but it is not clear with what 
kinetics it is extinguished or whether this may play an active role in attenuating Cdk1p activity. 
 
Regulation of Cytokinesis 
Critical for maintaining normal patterns of growth and division is the precise coupling of 
the nuclear division cycle with that of the cytoplasmic division cycle, the process known as 
cytokinesis. Cytokinesis occurs at the end of mitosis and results in the physical cleavage of one 
cell into two daughter cells. An outstanding question in mitotic control concerns how cytokinesis 
and mitosis are coupled to ensure the fidelity of the entire cell division process. Again, model 
systems, particularly budding and fission yeast, have paved the way for the development of an 
understanding as to how these events are coordinated. In these simple eukaryotes, a large amount 
of evidence points to the fact that while Cdk1p activity is necessary for constructing structures 
which will bring about cytokinesis, its elevated activity during mitotic progression inhibits the 
elements that trigger cytokinesis (Wheatley et al., 1997; Hwa Lim et al., 2003; Guertin et al., 
2000).  
 Initiation of cytokinesis in eukaryotes involves the regulated contraction of an actin and 
myosin based ring positioned between the segregated sister chromatids (reviewed by 
Balasubramanian et al., 2004; Wolfe and Gould, 2005). This structure is temporally regulated to 
only initiate ring contraction once sister chromatid separation is complete. In budding and fission 
yeast, analogous pathways termed the Mitotic Exit Network (MEN) and Septation Initiation 
Network (SIN), respectively, function at the end of mitosis to promote ring contraction and, in 
these organisms, synthesis of a cell wall (reviewed by Bardin and Amon, 2001; Simanis, 2003). 
These pathways are composed of a GTPase signaling cascade, which transmits the signal for 
cytokinesis through a number of effector protein kinases (Table 1). 
During late mitosis, these components become activated at the spindle pole body, the 
yeast counterpart to the mammalian centrosome, and transduce a signal for ring contraction, 
resulting in the movement of effector kinase(s) to the site of cell division (Sparks et al., 1999; 
Frenz et al., 2000). Component localization to the spindle pole body allows both the SIN and 
MEN pathways to be influenced by the nuclear division cycle via their close proximity to Cdk1p  
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Table 1. MEN and SIN proteins in S. cerevisiae and S. pombe  
 Function    S. cerevisiae    S. pombe 
Coiled-coil scaffold                    ?                                         Sid4p 
Coiled-coil scaffold                    Nud1p                                  Cdc11p 
ras-like GTPase                                                   Tem1p                                    Spg1p 
GEF                                            Lte1p                                                   ? 
2-component GAP                    Bfa1p                                               Byr4p 
2-component GAP                   Bub2p                                             Cdc16p 
Protein kinase                   Cdc15p                                             Cdc7p 
Protein kinase                         ?                                                  Sid1p 
Accessory protein                        ?                                                 Cdc14p 
Protein kinase                          Dbf2p/Dbf20p                                       Sid2p 
Accessory protein                              Mob1p                                             Mob1p 
Protein kinase                    Cdc5p                                               Plo1p 
Protein phosphatase                  Cdc14p                                         Clp1p/Flp1p  
Ring finger protein/inhibitor                      Dma1p/Dma2p                                       Dma1p             
 
 
(Morrell et al., 2004) as well as by the position of the elongating anaphase spindle where it 
comes into contact with cortical elements capable of triggering activation of the pathways. Such 
a mechanism has been very well documented for the inhibition of MEN activity achieved 
through the two-component GAP system for the Tem1p GTPase, composed of Bub2p and Bfa1p. 
Upon spindle pole body passage through the mother-bud neck, Bub2p and Bfa1p are inactivated 
and Tem1p comes into contact with its putative GEF, which initiates MEN signaling (Pereira et 
al., 2001; Bardin et al., 2000). S. pombe utilize a similar strategy for SIN inhibition during 
interphase and late mitosis. Byr4p and Cdc16p, the two-component GAP system operating in 
fission yeast, maintain SIN inactive through inhibition of the GTPase, Spg1p (Fankhauser et al., 
1993; Furge et al., 1998). Premature inactivation of this GAP complex uncouples cytokinesis 
from the nuclear division cycle. 
Cdk1p activity works with the GAP complexes to maintain the MEN and SIN inactive 
during mitotic progression. For example, budding yeast Cdc15p effector kinase is inhibited in 
vivo by Cdk1p-dependent phosphorylations (Jaspersen and Morgan, 2000). Similarly, high levels 
of Cdk1p inhibit fission yeast Sid1p kinase localization to the spindle pole body (Guertin et al., 
2000). Inhibiting the activity of certain SIN and MEN components creates an ideal mechanism to 
couple nuclear and cytoplasmic divisions, such that cytokinesis can only proceed upon 
elimination of Cdk1p activity (Figure 4A and 4B) (reviewed by Balasubramanian et al., 2000).  
 
CB ‘Cut’ ‘SIN’
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Mitosis Septation
A
Figure 4. Coordination of nuclear and cytoplasmic divisions in yeast. A) Relationship between activities
of Cdk1p versus SIN during mitotic progression. DAPI stained images showing normal coupling of 
nuclear and septation pathways. Cells are outlined in white to delineate cell boundary. B) DAPI 
stained images of instances where septation and the nuclear cycle are uncoupled. ‘Cut’ phenotype 
results from septation in the absence of chromosome segregation. ‘SIN’ phenotype results from a 
failure to prevent further rounds of nuclear division in the absence of septation, and is indicative of 
SIN mutants. C) Relationships among FEAR (Fourteen Early Anaphase Release) and MEN 
(Mitotic Exit Network) pathways in S. cerevisiae regulate the release of the Cdc14p phosphatase from
its nucleolar inhibitor. Adapted from Stegmeier and Amon, 2004.  
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While both the SIN and MEN control cytokinesis, only the MEN plays an additional 
essential function in the inactivation of mitotic Cdk1p activity. MEN mutants fail to exit mitosis 
and arrest as binucleate cells with segregated sister chromatids, high levels of the B type cyclin,  
Clb2p, and mitotic Cdk1p substrates in the hyperphosphorylated state (Visintin et al., 1998; 
Jaspersen et al., 1998). These mutants fail to activate the dual specificity phosphatase, Cdc14p, 
which catalyzes the dephosphorylation of mitotic Cdk1p substrates, and acts as the terminal 
effector of the MEN pathway (Figure 4C) (Jaspersen et al., 1998; Shou et al., 1999; Visintin et 
al., 1999). Although not essential for Cdk1p inactivation at mitotic exit, the SIN is required to 
prevent additional rounds of nuclear division in the absence of a complete cytokinesis event (Liu 
et al., 2000; Le Goff et al., 1999). This cytokinesis checkpoint monitors some element of the 
actin cytoskeleton and additionally requires the function of the inhibitory Wee1p kinase to 
inhibit Cdk1p and arrest cell division (Liu et al., 2000). In the absence of these functional 
pathways, nuclear division is not blocked. Whether this inhibition of Cdk1p activity occurs 
through a Cdc14 family member is unclear.  
 
Cdc14 protein phosphatases 
The Cdc14 family of protein phosphatases is conserved from yeast to humans and plays 
numerous roles during cell cycle progression (Figure 5A) (reviewed by Trautmann and 
McCollum, 2002). One constant among family members is the ability to specifically 
dephosphorylate substrates of the cyclin-dependent kinases (Gray et al., 2003; Kaiser et al., 
2002). These phosphatases are members of the dual specificity subfamily of protein tyrosine 
phosphatases. Structurally, they adopt a 2-domain architecture, arranged in tandem with each 
domain possessing a fold indicative of dual specificity phosphatases (Gray et al., 2003). While 
the more proximal domain (A domain) lacks the catalytic core required for phosphatase activity, 
it forms a pocket with the B domain (catalytic domain) necessary for substrate interactions. The 
B domain contains both the WPD (Trp-Pro-Asp) loop and the PTP (protein tyrosine 
phosphatase) motif, within which sit critical residues required for the hydrolysis of the 
phosphoester bond (Figure 5A and 5B) (Gray et al., 2003; Wang et al., 2004).  
 The best characterized member of this conserved family is the founding member, S. 
cerevisiae Cdc14p. Mutants in cdc14- display a MEN phenotype and prevent mitotic exit and 
cytokinesis by failing to properly inactivate Cdk1p in late mitosis (Visintin et al., 1998; Shou et  
WPD Motif PTP Motif
A
B
PTP Signature MotifNucleolar Targeting
Figure 5. Cdc14 family of protein phosphatases. A) Multiple sequence alignment of Cdc14 family
members (H. sapiens Cdc14A, H. sapiens Cdc14B, C. elegans Cdc14, S. pombe Clp1p, S. cerevisiae
Cdc14p) using ClustalW. Boxshade was used to delineate identical amino acids (black background) and
similar amino acids (gray background). A red box within the WPD and PTP motifs indicates Asp and 
Cys residues critical for phosphatase activity. B) Schematic representation of Cdc14 primary amino acid
sequence. Nucleolar targeting sequence is shown by a dark gray box, PTP signature motif is shown
in white box, and non-conserved C-terminus is shown by light gray box. 
A Domain                  B Domain
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al., 1999). Cdc14p acts as the terminal effector of this pathway since Cdc14p overproduction can 
rescue growth defects of all MEN mutants for their mitotic exit defects (Jaspersen et al., 1998). 
Many studies have established that Cdc14p brings about mitotic exit and Cdk1p inactivation by 
dephosphorylating at least three key substrates: the APC activator Cdh1p/Hct1p, the Cdk 
inhibitor Sic1p, and its transcription factor Swi5p (Visintin et al., 1998). In addition, Cdc14p 
targets a number of mitotic substrates at the end of mitosis to promote efficient cell cycle exit. It 
is not surprising then that Cdc14p is under intense regulation. Cdc14p is sequestered in an 
inactive state, bound to a competitive inhibitor Net1p/Cfi1p throughout the majority of the cell 
cycle, only being released at the metaphase to anaphase transition, where it relocates to the 
mitotic spindle, the spindle pole body, the kinetochore, as well as throughout the nucleus and 
cytoplasm (Shou et al., 1999; Stegmeier et al., 2002; Visintin et al., 1999; Pereira et al., 2002; 
Yoshida et al., 2002). Cdc14p release from this inhibition is achieved in two successive waves. 
The first, termed the FEAR network, occurs at the onset of anaphase and enables Cdc14p to 
perform a variety of functions necessary for a coordinated progression through anaphase 
(reviewed by D'Amours and Amon, 2004). The MEN pathway controls the second phase of 
Cdc14p release and promotes its full activation. A high degree of interplay occurs between 
Cdc14p and MEN components (Figure 4C). FEAR controlled release of Cdc14p in early 
anaphase initiates a positive feedback loop for MEN activation involving dephosphorylation of 
inhibitory phosphorylations on the MEN protein kinase Cdc15p (Stegmeier et al., 2002). 
Additionally, Cdc14p is also thought to control the termination of this signaling cascade as 
dephosphorylation and reactivation of the two-component GAP complex by Cdc14p at mitotic 
exit further silences MEN signaling (Pereira et al., 2002). Only subsequent to MEN activation 
can Cdc14p inactivate Cdk1p. How this inactivation is restricted temporally is not known. 
 Due to the unique manner in which budding yeast divide, it is currently unclear whether 
all organisms will rely so heavily on Cdc14 phosphatases for exit from mitosis. Knockdown 
experiments on C. elegans Cdc14 using RNAi results in embryonic lethality. However, these 
organisms die from a failure to complete cytokinesis, and not from a failure to exit mitosis 
(Gruneberg et al., 2002). CeCdc14 function seems to be required for stabilization of the midbody 
through localizing key spindle midzone factors. While a single Cdc14 homolog exists in S. 
cerevisiae, S. pombe, D. melanogaster, and C. elegans, two isoforms exist in mammals, Cdc14A 
and Cdc14B. Human Cdc14A and B have different patterns of localization in that throughout 
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interphase hCdc14A resides on the centrosome while hCdc14B is sequestered in the nucleolus 
(Mailand et al., 2002a) (Kaiser et al., 2002). Both of these isoforms are redistributed upon entry 
into mitosis as the centrosomes participate in formation of the mitotic spindle and the nuclear 
envelope breaks down. Because of these distinct localizations between the two isoforms, 
hCdc14A and hCdc14B are thought to regulate distinct cell cycle events. By localizing to the 
centrosome, hCdc14A is positioned to influence not only microtubule function, but also events 
that regulate G2/M transition as active Cdk1p first appears on the centrosomes (Jackman et al., 
2003). Consistent with this, deregulation of hCdc14A results in defects in the centrosome cycle 
as well as in cytokinesis defects (Kaiser et al., 2002; Mailand et al., 2002a). Because of the 
disparities between different Cdc14 family members and the processes they regulate, there is a 
need to study additional family members in other eukaryotes to determine whether there is a 
cohesive nature to their activities. While the negative regulation of Cdk does represent a 
conserved feature of Cdc14 family members (Gruneberg et al., 2002; Kaiser et al., 2002; 
Mailand et al., 2002a), their mechanisms of action may differ and be tailored to the unique 
challenges faced by each organism. The goal of this dissertation is to understand the function and 
regulation of the S. pombe Cdc14 family member, Clp1p, and how these processes contribute to 
the exit from mitosis.  
  
Summary 
 A rise in the activity of the conserved Cdk1-cyclin B complex initiates mitotic 
commitment and drives the phenotypic changes that occur during mitotic progression. Its activity 
must be attenuated after sister chromatid segregation has occurred to allow for mitotic exit and 
cytokinesis. As inappropriate Cdk1p activation is often associated with deregulated cell cycle 
events and genomic instabilities, a more complete understanding of its inhibitors is essential, as 
these gene products may represent potential tumor suppressors. One such negative regulator of 
Cdk1p activity is the conserved Cdc14 family of protein phosphatases. These phosphatases 
reverse Cdk1p dependent phosphorylation events during the exit from mitosis. Here, we examine 
the role that the Cdc14 family member in S. pombe, Clp1p, plays in Cdk1p activity attenuation 
during the exit from mitosis (Chapter III). We find that Clp1p disrupts the Cdk1p auto-
amplification loop in late mitosis to attenuate Cdk1p activity below a threshold that allows for 
activation of the SIN. We go on to show a mechanism as to how this disruption is restricted 
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temporally to occur only after the onset of anaphase (Chapter IV). This regulation involves 
Cdk1p mediated inhibition of Clp1p catalytic activity, and underscores the importance of 
positive and negative feedback loops that drive progression into and out of mitosis.  
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Strains, media, and methods 
The S. pombe strains used in this study (Table 2) were grown in YE or minimal medium with the 
appropriate supplements as previously described (Moreno et al., 1991). Strains were constructed 
by tetrad dissections or random spore analysis. DNA transformations were done by lithium 
acetate transformation (Keeney and Boeke, 1994). Induction of the nmt promoter (Maundrell, 
1993) was achieved by growing cells in thiamine (repressing conditions) and then washing cells 
three times in medium lacking thiamine (inducing conditions).  
 The clp1+ and cdc25+ ORFs were tagged at their 3’ ends with either the MYC-KanR, HA-
KanR, GFP-KanR, or TAP-KanR cassettes as previously described (Bahler et al., 1998). KanR 
transformants were screened by whole cell PCR and then visualized using fluorescent 
microscopy or detected through immunoblot analysis to ensure proper integration and expression 
of the fusion protein.  
 Gene replacements involving the clp1+ ORF were performed as described (Boeke et al., 
1984). Briefly, clp1::ura4+ cells were transformed with a genomic construct of clp1 in pIRT2 
vector carrying desired mutation(s). Recombinants were selected for in the presence of the drug, 
5-fluororotic acid (5-FOA) to counterselect against the presence of ura4+. Candidate colonies 
were screened for proper integration at the clp1+ locus by PCR.  
For synchronous cell cycle experiments, strains were centrifugally elutriated using a 
Beckman JE-5.0 rotor as described (Gould and Feoktistova, 1996). Early G2 cells were collected 
onto filters and resuspended in appropriate medium concentration. For cdc25-22 block and 
release experiments, cells were shifted to the restrictive temperature at 36°C for 4 hours. Cells 
were then released to the permissive temperature at 25°C to undergo a synchronous mitosis. For 
nda3-KM311 block and release experiments, cells were shifted to the restrictive temperature at 
18°C for 7 hours, and then released to the permissive temperature at 32°C to undergo a 
synchronous anaphase.   
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Table 1. Strains used in this study 
Strain       Genotype                 Source/Reference 
KGY 98  h90 wee1-50 mik1::ura4+ clp1::ura4+ uar4-D18 ade6-M21X leu1-32  This study 
KGY 100 h- mts3-1 cdc25-myc::ura4+ lid1-6 ura4-D18 ade6-M21X leu1-32  This study 
KGY 102 h- mts3-1 cdc25-myc::ura4+ skp1-A4 ura4-D18 ade6-M21X leu1-32  This study 
KGY 110 h- mts3-1 cdc25-myc::ura4+ clp1::ura4+ ura4-D18 ade6-M21X leu1-32 This study 
KGY 139 h+ clp1-HA:kanR ura4-D18 ade6-210 leu1-32    This study 
KGY 148 h- cdc25-GFP:kanR sid4-GFP:kanR clp1::ura4+ ura4-D18 ade6-M210 leu1-32 This study 
KGY 246 h- ade6-M210 ura4-D18 leu1-32             Lab stock 
KGY 297 h? nda3-KM311 cdc25-myc::ura4+ pub1::ura4+ ura4-D18 ade6-M21X leu1-32 This study 
KGY 434 h+ cdc3-124 ura4-D18 leu1-32     Lab Stock 
KGY 570 h? mts3-1 rad1::ura4+ cdc25-myc::ura4+ ura4-D18 ade6-M21X leu1-32 This study 
KGY 574 h- mts3-1 leu1-32       Lab stock 
KGY 612 h- wee1-50 mik1::ura4+ uar4D18 ade6M21X leu1-32   Lab stock 
KGY 655 h? cdc3-124 clp1::ura4+ ura4-D18 ade6-216 leu1-32   Trautmann, et al, 2001 
KGY 851 h- cdc25-22 ura4-D18 ade6-M21X leu1-32            Lab stock 
KGY 877 h+ cdc25-GFP:kanR sid4-GFP:kanR ura4-D18 ade6-M210 leu1-32  This study 
KGY 878 h- mts3-1 cut2-myc:kanR clp1::ura4+ ura4-D18 ade6-M21X leu1-32  This study 
KGY 1296 MATa trp1-190 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆  lys2::GAL1-HIS3 James, et al. 1996 
  GAL2-ADE2 met2::GAL-LacZ 
KGY 1687 h+ mts3-1 rad1::ura4+ ura4-D18      Lab Stock 
KGY 1744 h- cdc10-v50 ura4-D18 leu1-32     Lab stock 
KGY 1923 h- mts3-1 cut2-myc:kanR leu1-32     Berry et al, 1999 
KGY 1948 h- mts3-1 cut2-myc:kanR lid1-6 ade6-M21X ura4-D18 leu1-32     Berry et al, 1999 
KGY 2752 h+ cdc10-v50 clp1::ura4+ ura4-D18 ade6-M21X leu1-32    This study 
KGY 2877 h- leu1::pJK148-nmt1-clp1+ ura4-D18 ade6-210     This study 
KGY 2882 h- clp1-myc:kanR ura4-D18 ade6-M21X leu1-32     Trautmann, et al, 2001 
KGY 2940 h- leu1::pJK148-nmt1-clp1::C286S ura4-D18 ade6-M210   This study 
KGY 3159 h- leu1::pJK148-nmt1-clp1-TAP ura4-D18 ade6-210   This study 
KGY 3225 h? leu1::pJK148-nmt1-clp1-TAP wee1::ura4+ ura4-D18 ade6-M21X his3-237 This study 
KGY 3374 h- clp1-GFP:kanR ura4-D18 ade6-216 leu1-32    Trautmann, et al, 2001 
KGY 3377 h- cdc25-myc::ura4+ ura4-D18 leu1-32            Lopez-Girona et al, 1999 
KGY 3380 h- cdc25-22 clp1::ura4+ ura4-D18 ade6-M21X leu1-32         This study 
KGY 3381 h- clp1::ura4+ ade6-M210 ura4-D18 leu1-32                Trautmann, et al, 2001 
KGY 3388          h+ nda3-KM311 clp1-myc:kanR ade6-M216 leu1-32    This study 
KGY 3499 h+ cdc25-myc::ura4+ clp1::ura4-D18 ade6-M21X leu1-32     This study 
KGY 3612 h- nda3-KM311 ura4-D18 leu1-32     Lab stock 
KGY 3766 h+ cdc25-22 clp1-myc:kanR ura4-D18 ade6-M21X leu1-32    This study 
KGY 3783 h+ nda3-KM311 clp1::ura4+ ura4-D18 ade6-M21X leu1-32   This study 
KGY 3916 h+ nda3-KM311 cdc25-myc::ura4+ ura4-D18 ade6-M21X leu1-32  This study 
KGY 3920 h? nda3-KM311 clp1-TAP:kanR ura4-D18 ade6-M21X leu1-32  This study 
KGY 4213 h+ nda3-KM311 cdc25-myc::ura4+ clp1::ura4+ ura4-D18 ade6-M21X leu1-32 This study 
KGY 4337 h- cdc25-GFP:kanR ura4-D18 ade6-M210 leu1-32   This study 
KGY 4341 h- cdc25-GFP:kanR clp1::ura4+ ura4-D18 ade6-M210 leu1-32  This study 
KGY 4366 h+ mts3-1 cdc25-myc::ura4+ ura4-D18 ade6-M21X leu1-32   This study 
KGY 4593 h? cdc25-22 clp1::6A-myc:kanR ura4-D18 ade6-M21X leu1-32   This study 
KGY 4594 h- clp1::6A-myc:kanR ura4-D18 ade6-216 leu1-32   This study 
KGY 4604 h? nda3-KM311 clp1::6A-myc:kanR ura4-D18 ade6-M21X leu1-32   This study 
KGY 4605 h? nda3-KM311 clp1::D257A-myc:kanR ura4-D18 ade6-M21X leu1-32 This study 
KGY 4630 h+ nda3-KM311 clp1-GFP:kanR ura4-D18 ade6-M21X leu1-32  This study 
KGY 4687 h- clp1::D257A-myc:kanR ura4-D18 ade6-216 leu1-32   This study 
KGY 4807 h- clp1::8A-myc:kanR ura4-D18 ade6-216 leu1-32   This study 
KGY 4826 h? cdc3-124 clp1::6A-myc:kanR ura4-D18 ade6-216 leu1-32  This study 
KGY 4827 h? cdc3-124 clp1::8A-myc:kanR ura4-D18 ade6-216 leu1-32  This study 
KGY 4828 h? cdc3-124 clp1::D257A-myc:kanR ura4-D18 ade6-216 leu1-32  This study 
KGY 4884 h- clp1::6A/D257A-myc:kanR ura4-D18 ade6-216 leu1-32   This study 
KGY 4891 h+ nuf2-2        Nabetani, et al. 2001 
KGY 5018 h- clp1::C286S-myc:kanR ura4-D18 ade6-216 leu1-32   This study 
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Strain       Genotype                 Source/Reference 
KGY 5080 h-/h+ clp1-myc:kan/clp1-HA:kanR ura4-D18/ura4-D18 ade6-216/ade6-210 This study 
  leu1-32/leu1-32 
KGY 5124 h? cdc3-124 clp1-myc:kanR ura4-D18 ade6-216 leu1-32   This study 
KGY 5184 h- clp1::6D-myc:kanR ura4-D18 ade6-216 leu1-32   This study 
KGY 5364 h? nuf2-2 clp1-myc:kanR leu1-32     This study 
KGY 5365 h? nuf2-2 plo1-24C clp1-myc:kanR ura4-D18 ade6-M21X leu-32 his3-D1 This study 
KGY 5366 h? cdc3-124 clp1::6D-myc:kanR ura4-D18 ade6-216 leu1-32  This study 
KGY 5367 h? cdc3-124 clp1::C286S-myc:kanR ura4-D18 ade6-216 leu1-32  This study 
h? denotes the mating type was not determined in these studies 
 
 
Molecular biology techniques 
All plasmid constructions were performed by standard molecular biology techniques. Those used 
in this study are listed in Table 3. All DNA oligonucleotides were synthesized by Integrated 
DNA Technologies, Inc. (Iowa). All sequences were PCR amplified with Taq-Plus Precision 
(Stratagene) according to manufacturer’s protocol. Site-directed mutagenesis was carried out 
with Chameleon (Stratagene) or Quickchange (Stratagene) according to manufacturer protocols. 
Automated sequencing confirmed the presence of mutations and the fidelity of the sequence. The 
clp1+ ORF was amplified from a cDNA clone with oligonucleotides containing Nde1 and 
BamH1 at the 5’ and 3’ ends, respectively. The cdc25+ open reading frame was amplified from a 
genomic clone with oligonucleotides containing Nde1 and Sma1 at the 5’ and 3’ ends, 
respectively. All other constructs were subcloned from this construct by restriction digests or 
through PCR amplification.  
 
Cytology and Microscopy 
Cdc25p-GFP and Clp1p-GFP cells were grown in YE medium at 25°C and visualized live using 
an Ultraview LCI confocal microscope equipped with a 488-nm Ar ion laser (Perkin-Elmer). Z-
series optical sections were taken at 0.5 µm spacing, and images captured using Ultraview LCI 
software (version 5.2, Perkin-Elmer) and processed using Velocity software (version 1.4.2; 
Improvision). To visualize DNA and microtubules, cells fixed with ethanol were stained with 
DAPI (4,6-diamidino-2-phenylindole) and anti-TAT1 (tubulin) antibodies, respectively, as 
described (Chang et al., 2001). FACS analysis was performed as described (Breeding et al., 
1998). 
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Table 3. Plasmids Used in this Study 
Plasmid Name    Vector                  Insert 
pKG 45                 pMAL-2c    clp1+ 
pKG 47     pMAL-2c    clp1-C286S 
pKG 49     pREP1     cdc25+ 
pKG 367     pREP81     none 
pKG 368     pREP1     none 
pKG 596     pRMH41     none 
pKG 606     pRHA41     none 
pKG 1743    pGAD424    none 
pKG 1826    pMAL-2c    none 
pKG 2042    pJK148     nmt1-clp1+ 
pKG 2064    pJK148     nmt1-clp1-C286S 
pKG 2105    pGBT9     clp1+ 
pKG 2106    pGBT9     clp1-C286S 
pKG 2120    pJK148     nmt1-clp1-TAP 
pKG 2128    pGAD424    cdc25+ 
pKG 2191    pGAD424    cdc25 1-373 
pKG 2229    pGAD424    cdc25 303-596 
pKG 2430    pGAD424    cdc25 1-79 
pKG 2431    pGAD424    cdc25 1-197 
pKG 2432    pGEX4T     cdc25 1-191 
pKG 2439    pRHA41     clp1+ 
pKG 2440    pRHA41     clp1-C286S 
pKG 3420    pMAL-2c    clp1-D257A 
pKG 3421    pMAL-2c    clp1-6A 
pKG 3422    pMAL-2c    clp1-8A 
pKG 3425    pMAL-2c    clp1-6D 
pKG 3426    pSK     clp1+ 
pKG 3427    pSK     clp1-C286S 
pKG 3428    pSK     clp1-D257A 
pKG 3429    pSK     clp1-6A 
pKG 3430    pSK     clp1-8A 
pKG 3432    pSK     clp1-6A/D257A 
pKG 3433    pSK     clp1-6D 
pKG 3434    pIRT2     clp1+ 
pKG 3435    pIRT2     clp1-C286S 
pKG 3436    pIRT2     clp1-D257A 
pKG 3437    pIRT2     clp1-6A 
pKG 3438    pIRT2     clp1-8A 
pKG 3440    pIRT2     clp1-6A/D257A 
pKG 3441    pIRT2     clp1-6D 
pKG 3569    pMAL-2c    cdc25 1-79 
pKG 3570    pMAL-2c    cdc25 1-197 
pKG 3571    pMAL-2c    cdc25 1-373 
pKG 3572    pMAL-2c    cdc25+ 
pKG 3573    pMAL-2c    cdc25 79-197 
pKG 3574    pMAL-2c    cdc25 191-373 
pKG 3575    pMAL-2c    cdc25 191-596 
pKG 3576    pMAL-2c    cdc25 373-596 
pKG 3578    pMAL-2c    cdc25-15A 
pKG 3579    pRMH41     cdc25+ 
pKG 3580    pRMH41     cdc25-C480S 
pKG 3581    pRMH41     cdc25-15A 
pKG 3582    pRMH41     cdc25 79-596 
pKG 3583    pRMH41     cdc25 123-596 
pKG 3584    pRMH41     cdc25 191-596 
pKG 3585    pREP1     cdc25-15A 
pKG 3586    pREP81     cdc25-15A 
pKG 3587    pREP81     cdc25+ 
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Protein Lysates, Immunoprecipitations, Lysate Bindings, TAP Purifications, and 
Immunoblots  
 
Whole cell lysates were prepared by glass bead disruption in NP-40 buffer supplemented with 
protease inhibitors either in native or denaturing conditions as described (Gould et al., 1991). 
Native lysates were subjected to immunoprecipitation with anti-Cdk1p (4711), anti-HA 
(12CA5), or anti-MYC antibodies (9E10). Immunoblot analysis was performed as described 
(Tomlin et al., 2002) using either HRP conjugated secondary antibodies coupled with enhanced 
chemiluminescence or using fluorescent labeled secondary antibodies coupled with laser 
scanning on an Odyssey machine (LI-COR, NE) as described (Ohi et al., 2005). Tandem Affinity 
Purifications were performed as described (Tasto et al., 2001). For phosphatase assays, native 
lysates were prepared as before, and immunoprecipitated with 9E10 antibodies. Beads were 
washed extensively in NP-40 buffer, and then two to three times in phosphatase assay buffer (50 
mM Imidazole [pH 6.9], 1 mM EDTA, 1 mM DTT). Beads were then incubated at 30°C for 30 
to 45 minutes in phosphatase assay buffer containing recombinant phosphatases. Reactions were 
separated by SDS PAGE and visualized through immunoblot analysis as described (Tomlin et 
al., 2002). In vivo ubiquitination assays were performed as described (Benito et al., 1998; Berry 
et al., 1999). Lysate binding experiments were performed as described (Carnahan and Gould, 
2003). Yeast-2 hybrid analysis was performed as described (Carnahan and Gould, 2003). 
 
In vitro Kinase and Phosphatase Assays 
All recombinant bacterially produced proteins were purified on either glutathione beads (GST) or 
amylose beads (MBP) as described (Tomlin et al., 2002). Approximately 100 ng of recombinant 
Cdk1p kinase complex, purified from baculovirus infected insect cells as described (Yoon et al., 
2002), were used to phosphorylate approximately 1 µg of bacterially produced MBP-Cdc25p or 
MBP-Clp1p in HB15 buffer supplemented with 10 µM cold ATP and 5 µCi γ P32 ATP. 
Reactions were incubated at 30°C for 30 minutes and terminated by addition of sample buffer. 
Samples were boiled and separated by SDS PAGE. Coomassie staining or autoradiography was 
used for detection of proteins. For phosphatase assays, bacterially produced, soluble GST-
Cdc25p 1-197 or GST-Clp1p 348-537 was phosphorylated by kinase active Cdk1p complex as 
before and recovered on glutathione beads. Beads were washed extensively in TB1 buffer (50 
mM Tris-HCl [pH 8.0], 120 mM NaCl, 1 mM EDTA, 1 mM DTT) and eluted in TB1 buffer 
 24 
containing 20 mM glutathione. Eluted phosphorylated proteins were incubated in the presence of 
varying concentrations of recombinant phosphatase at 30°C for 45 minutes in phosphatase assay 
buffer. Reactions were terminated by addition of sample buffer and subsequent boiling. 
Reactions were separated by SDS PAGE and proteins visualized by Coomassie staining or 
autoradiography. Histone H1 kinase assays of Cdk1p immunoprecipitates were performed as 
described (Gould et al., 1991). 
 
Endogenous and Recombinant Cdc25p Activity Assays 
Endogenously tagged Cdc25p-MYC activity assays were performed as described (Kovelman and 
Russell, 1996) except lysates were immunoprecipitated with 9E10 antibodies. Briefly, 
immunoprecipitates containing Cdc25p-MYC were washed as described in Buffer C (Kovelman 
and Russell, 1996) supplemented with 0.1% Triton X-100, and incubated with inactive Cdk1p 
obtained from cdc25-22 (G2) lysates. Cdk1p was then re-isolated via immunoprecipitation and 
Histone H1 kinase assays were performed as described (Gould et al., 1991). Histone H1 assays 
were quantified by Cherkov scintillation counting. 
 Between 0.25 – 1 µg of recombinant MBP-Cdc25p were incubated with lysates 
containing inactive Cdk1p from cdc25-22 (G2). Cdk1p was then isolated via 
immunoprecipitation and Histone H1 kinase assays performed as described (Gould et al., 1991).  
 
Phosphatase Assays Involving Artificial Substrates 
pNPP (Sigma, MO) assays were performed as described (Montalibet et al., 2005). Briefly, 
approximately 2 µg of recombinant MBP-Clp1p were incubated in the presence of phosphatase 
assay buffer containing 20 mM pNPP at 30°C for 30 minutes. Reactions were terminated by 
addition of 0.25N NaOH and absorbance measured at 410 nm. DiFMUP (Invitrogen, CA) 
continuous assays were performed on Clp1p immune complexes obtained from 20 OD595 of cells 
as described (Gould et al., 1991) with the exception that cells were lysed in a modified NP-40 
buffer lacking sodium vanadate but containing instead 60 mM β-glycerophosphate. Clp1p 
immune complexes were resuspended in phosphatase assay buffer, supplemented with bovine 
serum albumin (New England Biolabs, MA) to 250 µg/mL, in a 96-well plate. DiFMUP was 
added via a FlexStation (Molecular Devices, CA) to a final concentration of 250 µM and 
fluorescence monitored over time with excitation at 385 nm and emission measured at 455 nm. 
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Fluorescent readings were plotted using Excel, and the rates of the reaction were determined 
using linear regression analysis. Protein quantifications for normalization were measured from 
1/5 of the assay input using Odyssey software (LI-COR, NE).  
 
In Vivo Labeling and Tryptic Phosphopeptide Mapping 
In vivo labeling was performed as described (Gould et al., 1991). Briefly, cells were grown 
overnight in phosphate-free medium containing 50 µM NaH2PO4 and appropriate supplements. 
Harvested cells were resuspended in phosphate-free medium containing 50 µM NaH2PO4 and 2-
8 mCi of [32P] orthophosphate and grown at 36°C for 4 hours. Extracts were prepared as 
described (Gould et al., 1991) and immunoprecipitated for desired protein. Immune complexes 
were resolved on SDS PAGE and transferred to PVDF membrane and exposed to film for 
autoradiography. Tryptic phosphopeptide mapping of labeled proteins was performed as 
described (Den Haese et al., 1995).  
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CHAPTER III 
 
Clp1p DISRUPTS THE Cdk1p AUTO-AMPLIFICATION LOOP DURING MITOTIC EXIT 
 
Introduction 
 Cdc14p plays an essential role in mitotic exit in S. cerevisiae by targeting cyclin B for 
degradation as well as activating an inhibitor of Cdk1p. Because budding yeast delay mitotic exit 
until both sister chromatid separation and traversal into the daughter bud have occurred, it has 
not been clear whether Cdc14p protein homologs from different eukaryotes play similar essential 
roles in mitotic exit. We have identified the S. pombe Cdc14p family member, Clp1p. While 
clp1+ is not essential for mitotic exit as in budding yeast, it is critical for maintaining the normal 
balance of Cdk1p activity at both the G2/M transition and during mitotic exit. Here, we detail 
Clp1p’s function in inhibiting Cdk1p activity through disruption of the Cdk1p auto-amplification 
loop during these transitions.  
 
Results 
Clp1 regulates the G2/M transition by promoting inhibitory Cdk1p phosphorylation 
 The following section describes work performed in collaboration with the laboratory of 
Dr. Dannel McCollum at the University of Massachusetts Medical School. Examination of the S. 
pombe genome database from the Sanger Centre revealed a predicted protein homolog (ORF 
SPAC1782.09c) of the CDC14 gene from S. cerevisiae. S. pombe Cdc14-like phosphatase 
(Clp1p, also known as Flp1p) shares 40% identity with budding yeast Cdc14p. Unlike CDC14, 
clp1+ is not essential for vegetative growth as disruption of the ORF with the ura4+marker in a 
diploid strain resulted in four viable spores (data not shown). Although viable, clp1∆ cells have 
noticeable growth defects, the most significant of which are a reduction in cell size at division 
and defects in cytokinesis. Whereas wild type cells divide precisely at 14 µm, clp1∆ cells divide 
at an average of 9.3 µm at 36°C (Figure 6A). This phenotype is indicative of a deregulated G2/M 
transition, occurring when the balance of activities between Cdc25p and Wee1p is tipped in 
favor of the mitotic state prematurely (Russell and Nurse, 1987). Consistent with this, strong 
overproduction of Clp1p from the inducible nmt1 promoter is toxic and led to a prolonged delay  
 
Figure 6. Clp1p regulates the G2/M Transition. A) Differential Contrast Images (DIC) of wild type (KGY
246) or clp1∆ (KGY 3381) cells grown at 36ºC. Scale bar represents 5 µm (Images taken from Trautmann,
et al, 2001). B) leu1::pJK148-nmt1-clp1 (KGY 2877) cells grown in either the presence of thiamine 
(repressing conditions, +T) or in the absence of thiamine (inducing conditions, -T) were fixed with ethanol
and stained with DAPI to visulaize nuclei. Asterisks indicate cells that have failed to septate between the 
segregating chromosomes.  C) leu1::pJK148-nmt1-clp1 (KGY 2877) cells were grown in the absence of 
thiamine for 14.5 hours at 32ºC, at which point small G2 cells were isolated by centrifugal elutriation. 
Samples were processed at the indicated time points for Histone H1 kinase activity, and levels of 
Cdk1p-p-tyr and Cdk1p by immunoblotting. D) leu1::pJK148-nmt1-clp1-Protein A (KGY 3159) and 
leu1::pJK148-nmt1-clp1-Protein A wee1∆ (KGY 3225) cells were grown in the absence of thiamine for 
12 hours at 32ºC, at which point small G2 cells were isolated by centrifugal elutriation. Septation index 
was determined by light microscopy. Wild type (KGY 246) cells were synchronized by centrifugal 
elutriation and used as control. E) Samples from elutriations in D) were prepared and the levels of 
Clp1p-Protein A and Cdk1p were determined by immunblot analysis.
cd
c2
5-2
2
nd
a3
-K
M3
11
0       30     60     90   120   150   180   210   225  240  255  270   285   300  315
leu1::pJK148-nmt1-clp1+
H1 Kinase
Cdk1p-p-Tyr
Cdk1p
Clp1p-Protein A
Cdk1p
w
ee
1+
w
ee
1 ∆
w
ee
1+
w
ee
1∆
0‘ 320’
Time (Minutes)
%
 S
ep
ta
te
d 
Ce
lls
0
10
20
30
40
50
60
70
80
90
100
0 50 100 150 200 250 300 350
leu1::pJK148-nmt1-
clp1
leu1::pJK148-nmt1-
clp1 wee1∆
wild type
A B
C
D E
time (min)
+ T                                   - T
*
*
27
 28 
in G2 phase of the cell cycle (Figure 6B). Synchronous cells overproducing clp1+ produced a 
delay in G2 for around 3 hours, a time period in which wild type cells underwent 2 successive  
divisions (Figure 6D). S. cerevisiae Cdc14p overproduction is also lethal, and promotes 
premature destruction of cyclin B prior to mitotic initiation (Visintin et al., 1998). During this 
delay upon overproduction of Clp1p, cyclin B was not destabilized prematurely (data not 
shown), but rather Cdk1p was maintained in the inhibited and Tyr-15 phosphorylated state 
(Figure 6C). As a result, Histone H1 kinase activity remained low throughout the time course. 
Once Clp1p overproducing cells entered mitosis, they suffered additional defects such as mitotic 
spindle defects (data not shown), nuclear positioning defects (data not shown), and often times 
septation occurring in the absence of proper sister chromatid segregation (Figure 6B, see 
asterisks). Because Wee1p is the primary kinase regulating Cdk1p Tyr-15 phosphorylation in S. 
pombe (Parker et al., 1992; Russell and Nurse, 1987), we tested whether the G2 delay required a 
functional Wee1p. When a similar amount of Clp1p was overproduced in a strain deleted for 
wee1+ (Figure 6E), no delay in mitotic progression was observed (Figure 6D). Overproduction of 
Clp1p in a wee1∆ background leads to an accumulation of multiple rounds of septation after 
entry into mitosis and as a result cells lose viability (Figure 6D and data not shown). Therefore, 
Wee1p lies functionally downstream of Clp1p in the regulation of the G2/M transition, and these 
data suggest that Clp1p overproduction results in the stabilization of activated Wee1p and 
potentially the inactivation of Cdc25p. An inability to activate Wee1p and inactivate Cdc25p in 
cells deleted for clp1+ could also account for its reduced cell size at division (see below). These 
events would likely be mediated through Clp1p dephosphorylation of Cdk1p phosphorylation 
sites on Wee1p and Cdc25p, thereby preventing mitotic entry through premature disruption of 
the Cdk1p auto-amplification loop. Consistent with a phosphatase dependent function for Clp1p 
in this process, Clp1p phosphatase activity was required for the imposed G2 delay (Figure 7A). 
In fact, strong overproduction of a catalytically inactive mutant, Clp1p-C286S, resulted in only a 
slight delay in the kinetics of progression through G2. Instead, these cells delayed progression 
through mitosis and delayed Cdk1p inactivation for approximately 80 minutes (Figure 7C). A 
high percentage of cells overproducing Clp1p-C286S failed to properly construct a bipolar 
spindle (Figure 7D), the failure of which often times led to incomplete genome segregation to 
both daughter cells (data not shown). The toxic effect of Clp1p-C286S overproduction is most  
 
Figure 7. Clp1p-C286S delays progression through mitosis. A) leu1::pJK148-nmt1-clp1-C286S 
(KGY 2940) were grown overnight at 32ºC in the presence (repressing conditions, +T) or absence of 
thiamine (inducing conditions, -T) prior to being fixed with ethanol and stained with DAPI to visualize 
nuclei. Asterisks indicate presence of cells that have undergone septation in the absence of chromosome 
segregation. B) wild type (KGY 246) cells transformed with pREP1:Empty vector (EV), 
leu1::pJK148-nmt1-clp1 (KGY 2877), and leu1::pJK148-nmt1-clp1-C286S (KGY 2940) were struck 
onto plates containing (+T) or lacking (-T) thiamine and grown for 48 hours at 32ºC. 
C) leu1::pJK148-nmt1-clp1-C286S (KGY 2940) cells grown in the absence of thiamine for 14.5 hours 
were synchronized to select for small G2 cells by centrifugal elutriation. Samples were taken at  the 
indicated time points and processed for Histone H1 activity and cyclin B (Cdc13p) and Cdk1p levels
through immunoblot analysis. D) leu1::pJK148-nmt1-clp1 (KGY 2877) and leu1::pJK148-nmt1-clp1-
C286S (KGY 2940) were grown in the absence of thiamine as in C) and processed for septation index by 
light microscopy. Inset, leu1::pJK148-nmt1-clp1-C286S (KGY 2940) cells from C) at 100’ were fixed 
with ethanol and visualized for microtubules via indirect immunofluorescence. 
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likely due to a failure to prevent septation in the absence of undergoing proper chromosome 
segregation (Figure 7A, see asterisks, and 7B). 
 
Regulation of Clp1p Localization 
 In this collaboration, our labs also demonstrated that, similar to budding yeast Cdc14p 
(Shou et al., 1999; Visintin et al., 1999), S. pombe Clp1p shows a dynamic pattern of localization 
during the course of the cell cycle. In particular, throughout interphase a functional Clp1p-GFP 
fusion localizes to the spindle pole body, the yeast counterpart to the mammalian centrosome, 
and to the non-DAPI staining region of the nucleus, which corresponds to the nucleolus (Figure 
8A). Upon entry into mitosis, Clp1p-GFP exits the nucleolus and localizes to the contractile ring 
and the forming mitotic spindle, as well as throughout the nucleus and cytoplasm (Figure 8B). 
This localization pattern appears to be a major source of Clp1p regulation as bulk protein levels 
do not fluctuate through the cell cycle (Figure 8D). Clp1p-GFP release prior to initiation of 
anaphase is distinct from the release of budding yeast Cdc14p, which does not occur until 
anaphase onset (Stegmeier et al., 2002; Pereira et al., 2002; Yoshida et al., 2002). To confirm 
this observation, we examined Clp1p-GFP localization in cells arrested with the nda3-KM311 
mutant, a mutation in β-tubulin that activates the spindle checkpoint in response to perturbations 
in the microtubule cytoskeleton (Hiraoka et al., 1984). Clp1p-GFP nucleolar signal is absent 
during this block, and Clp1p-GFP becomes distributed throughout the nucleus and cytoplasm, 
and is concentrated to the contractile ring and the kinetochore (Figure 8C). These data suggest 
that Clp1p is fully released from the nucleolus prior to the initiation of anaphase, and that Clp1p 
may play important roles during the early stages of mitotic progression (Trautmann et al., 2004).  
Additional data went on to support a model whereby Clp1p exits the nucleolus during 
early mitosis in a SIN independent manner, but its return to the nucleolus is prevented through 
sustained SIN activation (Trautmann et al., 2001; Cueille et al., 2001). That SIN activity 
sustained the release of Clp1p from the nucleolus was revealed through analysis of the 
cytokinesis checkpoint mutant, cps1-191. cps1-191 mutant cells, in response to a failure to 
initiate cytokinesis, arrest as binucleates possessing two G2  nuclei that are blocked prior to 
initiation of the next round of mitosis (Le Goff et al., 1999; Liu et al., 1999). Although they fail 
to undergo septation and cytokinesis, cps1-191 mutants arrest with active SIN signaling (Liu et 
al., 2000). Maintenance of the mitotic arrest requires the Wee1p inhibitory kinase as well as an  
Figure 8. Regulation of Clp1p through the cell cycle. A) clp1-GFP (KGY 3374) cells were grown at 
25ºC, fixed with Methanol, and stained with DAPI to visualize nuclei. B) Compression of image stacks
of asynchronous clp1-GFP (KGY 3374) cells grown at 25ºC in YE media. C) nda3-KM311 clp1-GFP
(KGY 4630) cells grown at 18ºC were viewed live for GFP fluorescence. Asterisk indicates position
of cell not yet arrested at the block point with Clp1p-GFP retained in the nucleolus. D) clp1-myc (KGY
2882) cells were grown at 32ºC overnight prior to synchronization by centrifugal elutriation. Samples
were processed for septation index via light microscopy (bottom panel) and for Clp1p and Cdk1p levels
via immunoblotting. 
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active SIN (Le Goff et al., 1999; Liu et al., 2000). During this block, Clp1p-GFP fails to localize 
to the nucleolus even though the cells are biochemically arrested in G2, a point in the cell cycle 
in which Clp1p is normally found in the nucleolus (data not shown). Providing a link between 
the SIN and Wee1p, Clp1p is additionally required to maintain this checkpoint (Figure 25B) 
(Trautmann et al., 2001; Cueille et al., 2001). This is presumably due to Clp1p indirect effects on 
contractile ring stability through its ability to maintain an active SIN (Mishra et al., 2004).   
A small percentage of clp1∆ cells fail at cytokinesis and show strong negative genetic 
interactions with mutants in the SIN pathway (data not shown). clp1∆ cytokinesis failure is 
exacerbated when combined with activating mutations of Cdk1p or inactivating mutations of 
Wee1p (data not shown). These data underscore the antagonistic action that elevated Cdk1p 
activity plays to SIN signaling during mitotic progression. Consistent with a role for Clp1p in 
cytokinesis, SIN signaling is attenuated in clp1∆ mutants (data not shown).   
 
Clp1p targets Cdc25p for dephosphorylation at mitotic exit 
Having established that Clp1p regulates the G2/M transition by promoting the inhibited, 
Tyr-15 phosphorylated form of Cdk1p, and that the Wee1p inhibitory kinase is necessary for this 
effect (Cueille et al., 2001; Trautmann et al., 2001), we wished to address whether or not Clp1p 
also influenced the function of the counterbalancing phosphatase, Cdc25p. To this end, we 
created two populations of synchronous cells through centrifugal elutriation both expressing 
endogenously tagged Cdc25p-MYC, either in a clp1+ background or in a deletion of it. Cdc25p 
levels were elevated in the absence of clp1+ at all cell cycle stages examined (Figure 9A).  
We next examined whether Cdc25p, a highly phosphorylated protein during mitosis 
(Kovelman and Russell, 1996; Moreno et al., 1990), was a target for dephosphorylation by Clp1p 
at mitotic exit. We utilized the reversible, cold-sensitive nda3-KM311, to arrest cells in an early 
mitotic state either in the absence or presence of clp1+. These cells were then released to the 
permissive temperature and monitored for Cdc25p levels and phosphorylation state by 
immunoblot analysis. As the clp1+ exited mitosis and septated (Figure 9C), Cdc25p became 
hypophosphorylated and slightly destabilized at the completion of mitotic exit. In the absence of 
clp1+, Cdc25p remained at high levels and in the hyperphosphorylated state (Figure 9B).    
 Clp1p may target Cdc25p at mitotic exit for dephosphorylation, and hence, inactivation, 
to help downregulate Cdk1p activity. To test if the hyperphosphorylated Cdc25p observed in the  
Figure 9. clp1+ regulation of Cdc25p. A) cdc25-myc (KGY 3377) or cdc25-myc clp1∆ (KGY 3499) 
were grown to mid-log phase and synchronized by centrifugal elutriation. Samples were taken after 
synchronization and processed for protein (A) and cell cycle stage by DAPI staining and cell 
measurement analysis as follows: G2 cells were uni-nucleate and 8-12 µm in length, Mitotic cells 
were uninucleate or binucleate cells with condensed chromatin, G1/S cells contained two interphase
nuclei and a septum (data not shown). Cdc25p-myc and Cdk1p were detected by immunoblotting with
9E10 and anti-PSTAIR antibodies, respectively. B) nda3-KM311 cdc25-myc (KGY 3916) and 
nda3-KM311 cdc25-myc clp1∆ (KGY 4213) were grown to mid-log phase and synchronized by cold
shift to 18°C for 7 hours. Cells were then released to the permissive temperature (32°C), and samples 
were collected at the indicated time points. Extracts were prepared from these and processed for 
immunoblot analysis. Completion of mitotic exit was monitored by determining binucleate formation
(C, top panel) and septation index (C, lower panel). For the Cdc25p immunoblot, samples were 
immunoprecipitated with 9E10 antibody and immunoblotted with anti-Cdc25p antibodies. D) Cells 
were synchronized as in B) and samples were collected at the indicated time points. Extracts were 
prepared and immunoprecipitated with 9E10 antibody. Samples were processed for Cdc25p activity 
and quantified and normalized to basal levels of activity (Unt) in E) indirectly via activation of 
Cdk1p’s Histone H1 activity as described in material and methods. In this experiment, Cdc25p activity
was a saturable reaction (data not shown).
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absence of clp1+ at mitotic exit is still active, we looked at Cdc25p activity from an nda3-KM311 
block/release experiment as before. In clp1Δ cells, Cdc25p activity was elevated and persisted  
even as cells exited mitosis, whereas wild type cells inactivated Cdc25p within 40 minutes after 
release (Figure 9D and 9E).  
Cdc25p localizes within the nucleus where it presumably encounters its substrate, Cdk1p, 
from the late stages of interphase until the mid stages of anaphase (Lopez-Girona et al., 1999). 
To determine if the lack of Clp1p led to increased amounts of nuclear Cdc25p, the cdc25+ 
endogenous locus was tagged at its C-terminus with a gfp cassette (Bahler et al., 1998) in the 
presence or absence of clp1+. clp1Δ cells showed a higher percentage of binucleates with nuclear 
Cdc25p-GFP staining than did wild type cells (Figure 10A, arrows). To quantify this, we created 
a cdc25+-gfp strain that also contained endogenously gfp-tagged sid4+. Sid4p is a constitutive 
spindle pole body component (a subcellular localization we have not observed for endogenous 
Cdc25p-GFP), and served as a marker for mitotic progression (Tomlin et al., 2002). In clp1+ 
cells, Cdc25p-GFP nuclear staining was observed in only 17% of late anaphase cells, whereas in 
the absence of clp1+ this percentage increased to 67% (Figure 10B and 10C). At this time, we 
can not distinguish whether the increased Cdc25p levels observed in the absence of clp1+ 
enhanced our ability to detect late anaphase nuclear fluorescence, as opposed to Clp1p 
specifically regulating rates of Cdc25p nuclear import/export.  
 
Clp1p promotes the destabilization and ubiquitination of Cdc25p 
 Cdc25p homologs in higher eukaryotes are degraded via ubiquitin-mediated proteolysis, 
often in response to DNA damage checkpoints (reviewed by Donzelli and Draetta, 2003). To 
address whether S. pombe Cdc25p is destabilized during G1 phase and whether or not this was 
clp1+ dependent, we expressed the catalytically inactive Cdc25p-C480S from the inducible nmt 
promoter in cells arrested in G1 with a cdc10-V50 allele. Thiamine (repressing conditions) was 
then added to the cultures along with cyclohexamide to prevent protein translation, and Cdc25p 
levels were monitored via immunoblot analysis. Cdc25p was nearly undetectable (see Asterisk in 
Long Exposure) in cdc10-V50 arrested cells (Figure 11A). However, in the absence of clp1+, 
Cdc25p was stabilized. FACS analysis confirmed that these cells remained in G1 at the end of the 
time course (Figure 11B). 
 
Figure 10. Cdc25p remains nuclear in clp1∆ anaphase B cells. A) Images of cdc25-GFP (KGY 4337) and
cdc25-GFP clp1∆ (KGY 4341) asynchronous cells grown at 25°C in YE medium. Asterisks (*) indicate 
binucleate cells without Cdc25p-GFP nuclear fluorescence. B) Compression of image stacks of 
cdc25-GFP sid4-GFP (KGY 877) and cdc25-GFP sid4-GFP clp1∆ (KGY 148) asynchronous cells grown
at 25°C in YE medium. Pointed arrows indicate binucleate cells with Cdc25p-GFP staining at the 
nuclear periphery. Solid arrowheads indicate binucleate cells with nuclear Cdc25p-GFP. Scale bar 
indicates 10 µM. C) Percentage of anaphase B cells with nuclear Cdc25p-GFP from (B). Anaphase B 
cells were those with 2 well separated spindle pole bodies (Sid4p-GFP) and no septum. 
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Figure 11.  Cdc25p destabilization and ubiquitination require Clp1p and APC/C. A) cdc10-V50 
(KGY 1744) and cdc10-V50 clp1∆ (KGY 2752) cultures expressing pREP41myc-cdc25C480S  were
grown in the absence of thiamine for 20 hours at the permissive temperature (25°C), shifted to the
non-permissive temperature (36°C) for 3.5 hours, at which point excess thiamine (4 µM) and 
cyclohexamide (100 µg/ml) were added to the cultures. Samples were taken at the indicated time
points. Extracts were prepared and immunoblotted with 9E10 and anti-PSTAIR to detect Cdc25p 
and Cdk1p, respectively. B)  Percentage of G1 cells from A) as determined by Sytox Green 
(Molecular Probes) staining and flow cytometry. C) In vivo ubiquitination assays. mts3-1 (KGY 574)
(lane 1), mts3-1 cut2-myc (KGY 1923) (lane 3), mts3-1 cut2-myc lid1-6 (KGY 1948) (lane 4), 
mts3-1 cut2-myc clp1∆ (KGY 878) (lane 5), mts3-1 cdc25-myc (KGY 4366) (lane 7), mts3-1 lid1-6 
cdc25-myc (KGY 100) (lane 8), mts3-1 skp1-A4 cdc25-myc (KGY 102) (lane 9), and mts3-1 clp1∆
cdc25-myc (KGY 110) (lane 10) strains transformed with pREP1-His6-Ubiquitin, and mts3-1 
cut2-myc (KGY 1923) (lane 2) and mts3-1 cdc25-myc (KGY 4366) (lane 6) transformed with empty
vector were grown at 25°C for 22 hours in the absence of thiamine to induce His6-Ubiquitin 
expression and then shifted to 36°C for an additional 4 hours. Samples were collected and extracts 
were prepared. Ubiquitin-conjugates were purified on Ni-NTA beads, separated on SDS PAGE, and
immunoblotted with 9E10 antibodies to detect Cut2p and Cdc25p.
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 Human Cdc25A and Cdc25C have been reported to be APC/C substrates, and in the case 
of Cdc25A, the SCF-ubiquitin dependent pathways as well (reviewed by Donzelli and Draetta, 
2003). To examine if destabilization of Cdc25p was due to ubiquitination, and which ubiquitin 
ligase(s) may be responsible, we employed an in vivo ubiquitination assay. As previously 
reported (Nefsky and Beach, 1996), Cdc25p is ubiquitinated in vivo (Figure 11C, lane 7). Use of 
temperature sensitive mutations in lid1-6, an APC/C mutant (Berry et al., 1999), and skp1-A4, a 
mutation that renders the SCF defective (Yamano et al., 2000), revealed that APC/C activity 
(Figure 11C, lane 8) was required for the in vivo ubiquitination of Cdc25p, while the SCF was 
dispensable (Figure 11C, lane 9). Interestingly, Clp1p was also required for Cdc25p 
ubiquitination (Figure 11C, lane 10). This is not due to a general APC/C defect in clp1Δ cells as 
ubiquitination of the APC/C substrate Cut2p was unaffected (Figure 11C, lane 5).  
 We additionally examined potential cis and trans acting factors involved in Cdc25p 
destabilization during mitotic exit. Cdc25p contains 5 putative destruction boxes (D-Box) 
matching the minimum consensus of Arg-X-X-Leu that could provide recognition by the APC/C 
(Figure 12A) (Glotzer et al., 1991). Again using the cdc10-v50 mutant to examine stability 
during G1, we expressed truncations of Cdc25p under the control of the exogenous nmt promoter. 
Whereas full length Cdc25p was highly destabilized during this arrest, deletion of the first 78 
amino acids from Cdc25p greatly stabilized the protein (Figure 12B). Because truncation of this 
N-terminal region eliminates only one putative D-Box, further truncations were made. 
Elimination of the first 122 and 190 amino acids resulted in a similar stabilization of Cdc25p 
during G1 (Figure 12B). These data suggest that N-terminal sequences present in Cdc25p target it 
for degradation during G1. Still, other elements intrinsic to Cdc25p must be acting to modulate 
its stability, since the turnover of these truncations did not fully mimic the absence of Cdc25p 
turnover observed in clp1∆ mutants. 
 Cdk1p phosphorylation of Cdc25A during mitosis protects the phosphatase from 
recognition by the APC/C (Mailand et al., 2000). Because Cdc25p is not efficiently 
dephosphorylated during mitotic exit in clp1∆ cells, it is possible that a similar mechanism may 
be operating within S. pombe Cdc25p. To address whether dephosphorylation of Cdc25p during 
mitotic exit by Clp1p targets it for destruction, we expressed a mutant of Cdc25p lacking the 15 
putative Cdk1p phosphorylation sites during a G1 arrest either in the presence or absence of 
clp1+. Elimination of these putative phosphorylation sites prevents Cdc25p  
Figure 12. cis and trans acting elements controlling Cdc25p stability. A) Schematic of Cdc25p 
depicting catalytic domain in gray, and presence of 5 putative destruction boxes shown by black vertical 
lines. Numbers underneath represent position of amino acids used for truncations B) cdc10-v50 
(KGY 1744) transformed with the indicated vectors were grown in the absence of thiamine for 20 hours 
at 25ºC before being shifted to 36ºC for 3 hours, at which point cyclohexamide (100 µg/mL) and excess 
thiamine (4 µM) were added to repress expression. Samples were processed at the indicated time points 
for Cdc25p and Cdk1p levels by immunoblot analysis. C) cdc10-v50 (KGY 1744) and cdc10-v50 
clp1∆ (KGY 2752) transformed with the indicated vectors were grown in the absence of thiamine for 20
hours at 25ºC before being shifted to 36ºC for 3 hours, at which point cyclohexamide (100 µg/mL) and 
excess thiamine (4 µM) were added to repress expression. Samples were processed at the indicated time 
points for Cdc25p and Cdk1p levels by immunoblot analysis. D) nda3-KM311 pub1∆ cdc25-myc 
(KGY 297) was shifted to the restrictive temperature for 7 hours at 18ºC, before being released to the 
permissive temperature of 32ºC. Samples were collected at the indicated time points and processed for 
Cdc25p levels and phosphorylation status and Cdk1p levels through immunoblot analysis, as well as for
% septation through light microscopy (right panel). 
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hyperphosphorylation in clp1∆ cells; however, Cdc25p-15A remains stable in the absence of 
clp1+ function (Figure 12C). These data suggest that mitotic phosphorylation of Cdc25p does not 
play a protective role, and that Clp1p plays a more direct role in Cdc25p destabilization than 
merely reversing phosphorylation events.  
The HECT-domain containing protein Pub1p has also been implicated in Cdc25p 
destabilization (Nefsky and Beach, 1996). To address whether Pub1p may play a role in 
promoting the destabilization of Cdc25p during mitotic exit, we utilized the reversible nda3-
KM311 mutant to block cells in early mitosis in the absence of pub1+ function. These cells were 
then released to the permissive temperature to exit mitosis and monitored for Cdc25p 
phosphorylation state and levels through immunoblot analysis. At the block point, Cdc25p levels 
are elevated in the absence of pub1+. However, as pub1∆ cells exit mitosis and undergo 
septation, Cdc25p became hypophosphorylated and destabilized (Figure 12D). These data 
suggest that while pub1+ does regulate Cdc25p stability, it does not do so during the exit from 
mitosis.  
 
Clp1p and Cdc25p interact in vivo 
 To determine whether we could detect an interaction between Clp1p and Cdc25p in vivo, 
we employed a reciprocal co-immunoprecipitation assay. In this experiment, catalytically 
inactive Clp1p (C286S) was expressed because it has been predicted to bind with higher affinity 
to its substrate (Tonks and Neel, 1996). Cdc25p-MYC specifically associated with a minor 
amount of Clp1p-HA when expressed from a multi-copy plasmid (Figure 13A). We obtained 
similar results when wild type Clp1p was expressed (data not shown). The low level of 
interaction between Cdc25p and Clp1p likely represents both the transient nature of the 
interaction as well as the possibility that many proteins may compete for Clp1p binding in vivo.  
To identify which domains of Cdc25p (Figure 13B) might be required for interaction 
with Clp1p, we utilized the yeast two-hybrid assay. Interaction of Clp1p and  
Cdc25p depended on the N-terminal 200 amino acids of Cdc25p (Figure 13C). To confirm this, 
Cdc25p fragments produced as MBP fusions were tested for their ability to bind Clp1p-MYC in 
cell lysates. All MBP-Cdc25p fragments containing the N-terminus but not MBP alone were able 
to interact with Clp1p-MYC confirming the two-hybrid data (Figure 13D).  
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Figure 13.  Clp1p interacts with the N-terminus of Cdc25p. A) wild type (KGY 246) or cdc25-myc
(KGY 3377) cells were transformed with empty vector or pREP41- HA-clp1C286S, and expression
was induced by growth in media lacking thiamine for 18 hours at 32°C. Samples were collected and
extracts were prepared. Native lysates were split, immunoprecipitated with 9E10 and 12CA5 
antibodies, and separated by SDS PAGE. Membranes were probed with 9E10 and 12CA5 antibodies 
to detect MYC and HA tagged proteins, respectively. B) Schematic representation of Cdc25p 
depicting carboxy terminal catalytic domain (gray box), putative Cdk1p phosphorylation sites (P), 
and 5 putative destruction boxes shown by black vertical lines. C) Strain PJ206 (KGY 1296) was 
co-transformed with bait plasmid pGBT9:clp1 and the indicated cdc25 fragments in the prey plasmid, 
pGAD424, and then screened for ability (+/-) to support growth on –His –Ade (double selection) plates.
D) Extracts were prepared from either wild type (KGY 246) (Unt) or clp1-myc (KGY 2882) strains 
grown in YE media at 32°C, and incubated in the presence of the indicated MBP-Cdc25p fragments 
bound to amylose beads. Beads were washed extensively and samples separated by SDS PAGE. 
Proteins were either detected by Coomassie blue staining or transferred to PVDF and subsequently 
probed with 9E10 antibodies to detect Clp1p. Asterisks (*) indicate the position of the predicted size
of the fusion protein on Coomassie stained gel.
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Cdk1p phosphorylates Cdc25p to Drive Mitotic Initiation 
Knowing that Cdc14p homologs specifically remove phosphorylation events positioned 
by proline-directed kinases (Gray et al., 2003; Kaiser et al., 2002; Visintin et al., 1998), coupled 
with evidence from Xenopus and human cells demonstrating that Cdk1p phosphorylates Cdc25p 
homologs both in vitro and in vivo (Izumi and Maller, 1993; Hoffmann et al., 1993), we tested 
whether recombinant S. pombe Cdk1p could phosphorylate Cdc25p in vitro. Cdc25p contains 15 
putative Cdk1p consensus sites for phosphorylation (Figure 14B). Recombinant Cdk1p complex, 
but not the kinase inactive complex, phosphorylated recombinant MBP-Cdc25p, but failed to 
phosphorylate MBP alone (Figure 14A). Truncation analysis coupled with site-directed 
mutagenesis revealed that Cdk1p possesses the potential to phosphorylate nearly all of the 15 
consensus sites in vitro (Figure 14C and 14D). In fact, all 15 Ser-Pro/Thr-Pro sites must be 
mutated to non-phosphorylatable Ala residues to abolish Cdk1p phosphorylation of Cdc25p in 
vitro (Figure 14D). In vitro, Cdk1p phosphorylates 4 major tryptic peptides, 3 of which reside in 
the N-terminal 200 amino acids (Figure 14E). Only a subset of these sites appear to be major in 
vivo sites of phosphorylation during a mitotic arrest, since mixing of phosphorylated tryptic 
peptides from in vivo and in vitro phosphorylation revealed many non-overlapping sites (Figure 
14F).  
Mitotic phosphorylation and activation of Cdc25p by Cdk1p has been predicted to affect 
the timing of mitotic commitment (Izumi and Maller, 1993; Hoffmann et al., 1993). In order to 
gain insight into how these phosphorylations may facilitate entry into mitosis, we expressed a 
mutant of Cdc25p lacking all 15 potential sites of Cdk1p phosphorylation, Cdc25p-15A, in cells. 
Both high and low levels of expression of Cdc25p and Cdc25p-15A from the inducible nmt 
promoter were sufficient to rescue growth of the cdc25-22 mutant allele at 36°C (Figure 15A). 
However, under repressing conditions (+ thiamine) from the low level nmt81 promoter, 
expression of Cdc25p-15A was unable to rescue temperature sensitivity, whereas expression of 
the wild type protein still rescued the growth defect (Figure 15A). High level expression of 
Cdc25p in S. pombe cells shortens the length of G2, and produces cells dividing with a 
characteristic “wee” phenotype (Figure 15B) (Russell and Nurse, 1986). However, full strength 
expression of Cdc25p-15A failed to advance mitosis prematurely (Figure 15B). Instead, 
expression of Cdc25p-15A delays progression through mitosis with a large number of cells 
possessing highly condensed chromatin (Figure 15B, see asterisks). These data demonstrate that  
Figure 14. Cdc25p is highly phosphorylated in vitro by 
Cdk1p. A) Approximately 1-2 µg of MBP and 
MBP-Cdc25p were phosphorylated in vitro with 
baculoviral produced and purified recombinant active (KA) or kinase dead (KD) Cdk1p complex. Reactions were 
separated by SDS PAGE and analyzed by Coomassie blue staining and autoradiography. B) Schematic representation 
of Cdc25p depicting putative Cdk1p phosphorylation consensus sites. The catalytic domain is shaded in gray, and the 
vertical lines refer to the amino acids used to begin or end various Cdc25p fragments. C) The indicated Cdc25p 
fragments fused to MBP were incubated in the presence of Kinase active (+) Cdk1p or Kinase dead (-) Cdk1p and 
radiolabeled ATP. Reactions were separated by SDS PAGE and either stained with Coomassie to visualize protein 
bands (right panel) or exposed to film for autoradiography (left 2 panels). D) MBP and MBP-Cdc25p phosphosite 
mutants were subjected to in vitro phosphorylation by kinase active Cdk1p. Reactions were resolved on SDS PAGE 
and stained with Coomassie to visulaize bands (bottome panel) and exposed to film for autoradiography (top panel). 
D) MBP, MBP-Cdc25p, GST, and GST-Cdc25 1-197 were subjected to in vitro phosphorylation by kinase active 
Cdk1p. Reactions were resolved on SDS PAGE and stained with Coomassie to visualize bands (right upper panel) or 
transferred to PVDF membrane and exposed to film for autoradiography (left upper panel). Bands corresponding to 
phosphorylated MBP-cdc25p and GST-cdc25p 1-197 were excised from membrane and subjected to tryptic 
phosphopeptide mapping as described in materials and methods. F) mts3-1 rad1∆ (KGY 1687) and mts3-1 rad1∆ 
cdc25-myc (KGY 570) cells were grown for 4 hours at 36ºC in the presence of 32P orthophosphate. Cdc25p-myc 
immunoprecipitates were resolved on SDS PAGE and exposed to film for autoradiography (top panel). Tryptic peptides
from the in vivo labeling were mixed with those produced upon incubation of Cdk1p with MBP-Cdc25p in vitro and 
separated in 2 dimensions on TLC plates and exposed to film for autoradiography (lower panel). Circles represent 
tryptic fragments that are present in both the in vivo and in vitro maps.
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Figure 15. Cdc25p-15A shows reduced activity in vivo but not in vitro. A) cdc25-22 (KGY 851) cells 
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Cdc25-15A has reduced activity in vivo. To determine whether this reduced in vivo activity 
stems from a reduction in catalytic activity in vitro, we assayed Cdc25p-15A in vitro activity as a 
function of its ability to activate Tyr-15 phosphorylated Cdk1p, obtained from cdc25-22 mutant 
cells (Kovelman and Russell, 1996). Recombinant MBP-Cdc25p and MBP-Cdc25p-15A activate 
Cdk1p’s Histone H1 kinase activity with similar concentration dependencies, whereas MBP 
alone failed to activate Cdk1p (Figure 15C). Additionally, MBP-Cdc25p-15A retains the ability 
to interact with Clp1p-MYC from S. pombe cell lysates (Figure 15D). Together, these data 
suggest that despite Cdc25p-15A possessing full catalytic activity in vitro and interacting with 
known interacting proteins, the phosphosite mutant displays a reduced ability to drive mitotic 
progression in vivo.  
 
Clp1p reverses Cdk1p-dependent phosphorylation events on Cdc25p 
 We next examined whether or not recombinant MBP-Clp1p could dephosphorylate 
recombinant GST-Cdc25p 1-197 when phosphorylated in vitro by active Cdk1p complex. MBP-
Clp1p, but not a phosphatase dead version in which the catalytic Cysteine-286 is replaced by 
Serine (MBP-C286S) (Denu et al., 1996), removed radioactive phosphate from Cdc25p in a 
dose-dependent fashion (Figure 16A). Furthermore, both MBP-Clp1p and λ phosphatase, but not 
MBP-C286S, could dephosphorylate Cdc25p immunoprecipitated from mitotically arrested S. 
pombe cells (Figure 16B). Approximately five times the amount of λ PPase was added (~500 ng) 
to achieve similar levels of dephosphorylation.  
 
clp1Δ cells delay mitotic Cdk1p inactivation and advance G2 due to stabilized Cdc25p 
Having established that in the absence of clp1+ Cdc25p is upregulated during many 
stages of the cell cycle, we wanted to know if this resulted in higher Cdk1p activity at 
inappropriate times. To this end, we examined synchronous cell populations either in the 
presence or absence of clp1+ using a cdc25-22 arrest/release protocol. 90 minutes after release of 
the wild type population, the completion of cell division had nearly been reached (Figure 17A). 
However, in the absence of clp1+ at the 90 minute time point, the septation peak had not been 
reached and did not occur for an additional 20 minutes (Figure 17A and data not shown). This 
could result from a septation defect or a delay at any point prior to this. To pinpoint the delay, we 
examined the microtubule cytoskeleton of the cells and quantified the percentages of metaphase  
Figure 16.  Clp1p reverses Cdk1p dependent phosphorylation of Cdc25p. A) Approximately 100 ng of 
GST-∆Cdc25p containing amino acids 1-197 was phosphorylated by recombinant Cdk1p complex in
vitro, and subsequently incubated with the indicated amounts of MBP-C286S or MBP-Clp1p.
Reactions were separated by SDS PAGE, and analyzed by Coomassie blue staining and 
autoradiography. B) Cell pellets from nda3KM311cdc25-myc (KGY 3916) arrested at the restrictive 
temperature (18°C), and wild type (KGY 246-Unt) and cdc25-myc (KGY 3377-Asyn) grown to 
mid-log phase were collected. Extracts were prepared and immunoprecipitated with 9E10 antibodies
and subsequently incubated with phosphatase buffer alone (lanes 1, 2, and 3), 100 ng MBP-C286S 
(lane 4), 100 ng MBP-Clp1p (lane 5), or 0.5 µg Lambda phosphatase (lane 6). Reactions were 
separated by SDS PAGE and immunoblotted with anti-Cdc25p antibodies. Asterisk (*) indicates 
position of the hyperphosphorylated Cdc25p. 
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Figure 17. clp1∆ cells delay Cdk1p inactivation at the end of mitosis. cdc25-22 (KGY 851) and cdc25-22 
clp1∆ (KGY 3380) cells were arrested in G2 by incubation at 36°C for 4 hours. Cultures were then 
released to 25°C, and samples were taken at the indicated time points and fixed with ethanol or frozen. 
A) Septation index was calculated using a light microscope (A, top panel). Ethanol fixed samples were 
subjected to indirect immunofluorescence with anti-TAT1 antibodies (A, bottom panel). The presence of 
elongated spindles and separated DNA masses was assessed in at least 200 cells. B) Cell pellets were 
lysed under native conditions and immunoprecipitated for Cdk1p with 4711 antibody. Samples were 
processed for Histone H1 kinase activity and immunoblotted for Cdk1p levels with anti-PSTAIR. 
C) nda3-KM311 (KGY 3612) and nda3-KM311 clp1∆ (KGY 3783) were arrested in prometaphase by 
incubation at 18°C for 6.5 hours. Cells were released at 32°C, and ethanol fixed samples and cell pellets
were collected at the indicated time points. Septation index was determined as in A) (C, lower panel) and
fixed cells were stained with DAPI to visualize nuclei. The presence of separated DNA masses and no 
septum was assessed in at least 200 cells (C, top panel). D) Cell pellets were analyzed as in B) and Cdk1p
activity was quantified E). 
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and anaphase B spindles (Figure 17A and data not shown). In the presence of clp1+, anaphase 
began at 30 minutes and spindles disassembled by 60 minutes as septation began (Figure 17A). 
This was in marked contrast to the timing of anaphase in the absence of clp1+ where spindle 
elongation began with a 10-minute delay, and elongated spindles persisted until the end of the 
time course (Figure 17A). Because spindle disassembly is inhibited by elevated Cdk1p activity 
(Wheatley et al., 1997), we examined Cdk1p activity through immunoprecipitation kinase 
assays. clp1Δ cells delayed Cdk1p inactivation for 20-30 minutes compared to control cells 
(Figure 17B).  
A second method of synchronization was used to assess anaphase progression in clp1Δ 
cells to eliminate the possibility that the observed delay was specific to the cdc25-22 allele. 
nda3-KM311 cells were arrested in early mitosis in the presence or absence of clp1+, and then 
released to the permissive temperature to allow anaphase progression. clp1Δ cells delayed 
septation by 10 minutes (Figure 17C), and mitotic Cdk1p activity was not returned to interphase 
levels until 40 minutes after release (Figure 17D and 17E). This is in contrast to wild type cells, 
which inactivated Cdk1p 20 minutes after release (Figure 17D and 17E). The more pronounced 
exit defect observed with the cdc25-22 arrest/release protocol likely represents a combination of 
the better synchrony achieved with this protocol as well as the slower kinetics of cell cycle 
progression at 25°C. 
To examine if the mitotic exit delay was at least in part due to hyperactive Cdc25p in 
clp1Δ cells, we again utilized the cdc25-22 arrest/release protocol either in the presence or 
absence of clp1+. These cells were released to the permissive temperature to allow mitotic entry. 
As soon as cells entered mitosis, as judged by formation of mitotic spindles and an elevation of 
Cdk1p kinase activity (Figure 18B and data not shown), the cultures were divided in half. One 
half of the culture was shifted to the restrictive temperature to once again inactivate Cdc25-22p, 
while the other half was left to progress through mitosis at the permissive temperature. As 
before, when kept at the permissive temperature, clp1Δ cells exited mitosis with a 20-30 minute 
delay as judged by spindle disassembly and mitotic Cdk1p inactivation (Figures 18A and 18B). 
However, when Cdc25-22p was inactivated subsequent to Cdk1p activation, clp1Δ cells 
disassembled mitotic spindles and inactivated Cdk1p with only a 10-minute delay (Figures 18A 
and 18B). This slight delay could result from slow inactivation of Cdc25-22p, or suggests that 
Clp1p functions through additional mechanisms to promote Cdk1p inactivation. These data  
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Figure 18. Exit delay and G2 advancement depend in large on Cdc25p. A)  cdc25-22 (KGY 851) and 
cdc25-22 clp1∆ (KGY 3380) were arrested in G2 by incubation at 36°C for 4 hours and released to 25°C
to undergo a synchronous mitosis. Timing of mitotic entry was judged by Histone H1 kinase assays as 
well as microtubule staining for metaphase spindles in several previous experiments and confirmed in this
one. After cells entered mitosis (20 minutes for wild type and 30 minutes for clp1∆), the cultures were 
spilt in half, and incubated either at 25°C (permissive) or 36°C (non-permissive). Ethanol fixed samples 
and cell pellets were taken at the indicated time points. A) Septation was determined by light microscopy
(A, top panel). Ethanol fixed samples were subjected to indirect immunofluorescence with anti-TAT1 
antibodies (A, bottom panel). The presence of elongated spindles and separated DNA masses was 
assessed in at least 200 cells. B) Cell pellets were lysed under native conditions and immunoprecipitated
for Cdk1p with anti-4711. Lysates were processed for Histone H1 kinase activity and immunoblotted for
Cdk1p with anti-PSTAIR antibodies. C) Differential Interference Contrast Images of wee1-50 mik1∆ 
(KGY 612) and wee1-50 mik1∆ clp1∆ (KGY 98) grown at 25°C in YE medium. Cell lengths at septation
were scored from at least 20 cells using Openlab software (Improvision). Scale bar indicates 10 µm. D-E)
wee1-50 mik1∆ (KGY 612) and wee1-50 mik1∆ clp1∆ (KGY 98) cells grown at 25°C were synchronized
by centrifugal elutriation. Cells were released to the restrictive temperature (36°C), and samples taken at 
the indicated time points were processed for % septation (D) and for protein. E) Lysates were prepared 
under native conditions and separated on SDS PAGE. Membranes were immunoblotted for Tyr-15 
phosphorylated Cdk1p and total Cdk1p with phospho-Tyr-15 Cdk1p and PSTAIR antibodies, respectively.
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cumulatively argue that the mitotic exit defect of clp1Δ cells is due in part to the persistence of 
Cdc25p activity.  
 We and others have shown previously that clp1Δ cells enter mitosis at a premature cell 
size (Figure 6A) (Cueille et al., 2001; Trautmann et al., 2001). As previously mentioned, this 
could result from inhibition of Wee1p, activation of Cdc25p, or a combination of the two. 
Because we demonstrated defective downregulation of Cdc25p levels in clp1Δ cells, we 
determined if elevated Cdc25p activity was contributing to the G2 advancement of clp1Δ cells. 
wee1-50 mik1Δ cells lose Tyr-15 kinase activity upon shift to the restrictive temperature, and 
therefore the rate at which these cells enter mitosis is entirely dependent upon the amount of 
Cdc25p activity (Rhind et al., 1997). We examined the rates of mitotic entry in wee1-50 mik1Δ 
cells in the presence or absence of clp1+. A synchronous population of G2 cells were obtained by 
centrifugal elutriation and immediately shifted to the restrictive temperature to inactivate Wee1p 
kinase activity. clp1Δ cells dephosphorylated Tyr-15 of Cdk1p 15 minutes earlier than wild type 
cells (Figure 18E). They also reached the peak of septation 15-30 minutes earlier than control 
cells (Figure 18D). Even at the permissive temperature, the triple mutant (wee1-50 mik1Δ clp1Δ) 
divides at a smaller cell size (8.5 µm as opposed to 10.2 µm) than does the double mutant 
(Figure 18C). Together, these data suggest that loss of clp1+ function acts additively with loss of 
wee1+ function and that increased Cdc25p activity during G2 advances mitotic commitment in 
the absence of clp1+.  
 
Summary 
 Cdc14p protein phosphatases reverse mitotic Cdk1p phosphorylation events (Gray et al., 
2003; Kaiser et al., 2002). We have described the initial characterization of the S. pombe Cdc14p 
family member, Clp1p. Unlike its S. cerevisiae counterpart, Clp1p is not essential for mitotic 
exit. However, we have shown that Clp1p plays critical roles in balancing the activity of Cdk1p 
during both the G2/M transition and during the exit from mitosis. Deletion of clp1+ produces 
small, but viable cells, whereas overproduction of Clp1p delays progression through G2. These 
phenotypes result from an alteration in the balance of activities of the Wee1p inhibitory kinase 
and the Cdc25p phosphatase, which together regulate the Tyr-15 phosphorylation state of Cdk1p. 
We have shown that Clp1p directly inhibits Cdc25p activity through two potentially distinct 
mechanisms. First, it dephosphorylates Cdc25p during the exit from mitosis to attenuate its 
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increased activity, and second, Clp1p promotes the ubiquitination and destabilization of Cdc25p. 
Both of these elements may represent conserved features of mitotic control by Cdc14 
phosphatases, as Cdc25p homologs in higher eukaryotes are regulated at the post-translational 
level via phosphorylation and protein degradation. We hypothesize that Clp1p functions together 
with the SIN to downregulate Cdk1p activity below a certain threshold competent for cytokinesis 
and the cycle to reset (Figure 19). A key question arising from these studies is how the disruption 
of the Cdk1p auto-amplification loop is temporally regulated to ensure that mitotic exit is not 
prematurely catalyzed. 
 
 
 
 
Figure 19. Positive and negative regulation of Cdk1p during mitosis. During mitosis, Cdk1p 
stimulates its own activity by activating its positive regulator (Cdc25p) and inactivating its 
negative regulators (Wee1p, SIN, Clp1p). As Cdk1p activity is sufficiently downregulated at 
mitotic exit, SIN and Clp1p function together to combat Cdk1p activation by reversing the auto-
amplification loop and promoting cytokinesis.  
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CHAPTER IV 
 
REGULATION OF Clp1p DURING MITOTIC PROGRESSION 
 
Introduction 
 Clp1p is released from the nucleolus early in mitosis when it redistributes to the forming 
mitotic spindle, the kinetochores, and the contractile ring, as well as to the nucleus and 
cytoplasm (Figure 8B) (Cueille et al., 2001; Trautmann et al., 2001; Trautmann et al., 2004). 
This is in contrast to Cdc14p localization in budding yeast, where nucleolar release of the 
phosphatase does not occur until anaphase onset (Stegmeier et al., 2002; Pereira et al., 2002; 
Yoshida et al., 2002). Released Cdc14p correlates with its activation as a phosphatase and its 
ability to target substrates (Visintin et al., 1999; Shou et al., 1999). Because of the disparity in 
localization patterns between the two Cdc14 homologs, we wanted to determine if S. pombe 
Clp1p was under any additional modes of regulation during progression through the early stages 
of mitosis, which may influence its ability to interact with and dephosphorylate its substrate(s). 
Here, we describe mitotic specific phosphorylation of Clp1p by the mitotic regulator, Cdk1p, and 
show that the result of this phosphorylation is inhibition of Clp1p catalytic activity both in vitro 
and in vivo. As Cdk1p activity falls upon anaphase initiation, Clp1p auto-catalytically reverses 
these phosphorylation events, thus allowing its subsequent dephosphorylation of key substrate(s).  
 
Results 
Cdk1p phosphorylates Clp1p during early mitosis 
As previously reported, Clp1p becomes hyperphosphorylated as cells progress through 
mitosis (Figure 20B and 21A) (Cueille et al., 2001). In particular, Clp1p accumulates in the 
hyperphosphorylated state during prometaphase, an arrest achieved with the nda3-KM311 
mutant (Hiraoka et al., 1984). Clp1p phosphorylation is not just a consequence of its nucleolar 
release since it accumulates in the hypophosphorylated state in cells arrested using the 
cytokinesis checkpoint mutant, cdc3-124 (Figure 20B), a mutant in which Clp1p is maintained 
out of the nucleolus (Trautmann et al., 2001). In an effort to determine the role of mitotic 
phosphorylation of Clp1p, we biochemically purified Clp1p using a TAP (Tandem Affinity  
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Figure 20. Clp1p is hyperphosphorylated on Ser and Thr residues in early mitosis. A) Schematic of
Clp1p primary amino acid sequence. Dark box at N-terminus depicts the nucleolar targeting sequence,
medium gray box depicts catalytic core domain, within which sits the characteristic PTP Signature 
Motif shown by a white box, and the light gray box depicts the non-conserved C-terminus. P represents
putative Cdk1p consensus sites of phosphorylation. P with Asterisks (*) over them represent Cdk1p
consensus sites identified through mass spectrometric analysis. B) wild type (KGY 246-Unt) and  
clp1-myc (KGY 2882-Asyn) cells grown at 32ºC, cdc25-22 clp1-myc (KGY 3766) and cdc3-124 
clp1-myc (KGY 5124) cells grown at 36ºC, and nda3-KM311 clp1-myc (KGY 3388) cells grown at 18ºC
were processed for Clp1p levels and phosphorylation status by immunoblot analysis. C) nda3-KM311 
clp1-TAP (KGY 3920) cells grown at 18ºC were processed through Tandem Affinity Purification and the 
resulting proteins were resolved on SDS PAGE and silver stained (right panel) or phosphorylated Clp1p
peptides identified by mass spectrmetric analysis. Left panel indicates partial tryptic peptides identified
as being phosphorylated with amino acid residue shown at left. 
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Figure 21. Clp1p is phosphorylated in vivo and in vitro by Cdk1p. A) cdc25-22 clp1-myc (KGY 3766)
and cdc25-22 clp1::6A-myc (KGY 4593) were synchronized at the G2/M boundary for 4 hours at 36ºC
and released to the permissive temperature at 25ºC to enter a synchronous mitosis. Samples were taken at
the indicated time points and processed for cell cycle stage by microscopy or for Clp1p and Cdk1p levels
via immunblot analysis. B) clp1-myc (KGY 2882), clp1::6A-myc (KGY 4594), and nda3-KM311 clp1-myc
(KGY 3388) and nda3-KM311 clp1::6A-myc (KGY 4604) cells grown at the restrictive temperature of 
18ºC for 7 hours were processed for Clp1p phosphorylation status in the presence or absence (+/-) of 
Lambda Phosphatase (λ). Lower panel. cdc25-22 (KGY 851), nda3-KM311 clp1-myc (KGY 3388), and 
nda3-KM311 clp1::6A-myc (KGY 4594) were processed for Histone H1 activity. C) Recombinant MBP 
and MBP-Clp1p were subjected to in vitro kinase assays in the presence of Kinase Active (+) or Kinase
Dead (-) Cdk1p. Reactions were resolved on SDS PAGE, Coomassie stained, and exposed to film for 
autoradiography.
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Purification) tag from cells arrested in early mitosis with the nda3-KM311 mutant. A portion of 
the purification was resolved on SDS PAGE and silver stained (Figure 20C, right panel), while 
the rest was treated with proteases and the peptides identified by 2D-LC tandem mass 
spectrometry. SEQUEST analysis identified 6 Ser and Thr phosphorylation sites (Figure 20C, 
left panel). Mutation of these putative phosphorylation sites to non-phosphorylatable Ala 
residues resulted in a Clp1p mutant severely impaired for mitotic phosphorylation (Figure 21A 
and 21B), despite cell cycle progression and Cdk1p Histone H1 kinase activity being largely 
unaffected (Figure 21A and 21B). Because these Ser and Thr sites corresponded to Cdk1p 
consensus sites of phosphorylation (Ser/Thr-Pro-X-Lys/Arg), we subjected recombinant Clp1p 
produced from bacteria to in vitro phosphorylation with recombinant Cdk1p. While kinase active 
Cdk1p phosphorylated recombinant Clp1p very well in vitro, it was unable to phosphorylate 
MBP alone. Additionally, kinase dead Cdk1p was unable to phosphorylate recombinant Clp1p 
(Figure 21C).  
 
Clp1p controls its own dephosphorylation in vivo 
 Similar to the actions of Cdks, Cdc14p phosphatases are directed towards Ser and Thr 
residues (when phosphorylated, in the case of Cdc14p) with an additional Pro at the  +1 position 
(Gray et al., 2003; Kaiser et al., 2002). Because Cdk1p can phosphorylate Clp1p in vitro and 
Cdk1p consensus sites are phosphorylated in vivo, the intriguing possibility was raised that 
Clp1p controlled its own dephosphorylation. To examine the kinetics of Clp1p 
dephosphorylation, we again utilized the nda3-KM311 mutant to block cells in a 
hyperphosphorylated state in early mitosis. These cells were then released to the permissive 
temperature and allowed to exit mitosis synchronously. As cells exited mitosis, Clp1p became 
hypophosphorylated with kinetics similar to the inactivation of Cdk1p (Figure 22A and data not 
shown). In order to test whether or not Clp1p phosphatase activity was required for this 
hypophosphorylated state during mitotic exit, we generated phosphatase dead (PD) mutants of 
Clp1p (C286S and D257A) at the endogenous clp1+ locus. These mutants behaved 
phenotypically identical and were used interchangeably throughout these studies (Figure 24A 
and data not shown). When phosphatase dead Clp1p (Clp1p-PD) was released from the nda3-
KM311 block, Clp1p-PD remained in the hyperphosphorylated state even as cells exited mitosis 
and underwent septation (Figure 22B). In fact, expression of phosphatase dead Clp1p produced a  
Figure 22. Clp1p auto-dephosphorylates in vivo during the exit from mitosis. A) nda3-KM311 clp1-myc
(KGY 3388) or B) nda3-KM311 clp1::D257A-myc (KGY 4605-PD) were shifted to the restrictive 
temperature of 18ºC for 7 hours, then released to the permissive temperature of 32ºC to allow a 
synchronous exit from mitosis. Samples were prepared at the indicated time points and processed for 
septation index via light microscopy (lower panel) or for Clp1p and Cdk1p levels through immunoblot 
analysis (upper panel). C) Asynchronous wild type (KGY 246-Unt), clp1-myc (KGY 2882-+), 
clp1::D257A-myc (KGY 4687-PD), clp1::6A/D257A-myc (KGY 4884-6A/PD), or clp1::6D-myc 
(KGY 5184-6D) were processed for Clp1p phosphorylation status after treatment with (+/-) Lambda 
Phosphatase (λ) via immunoblot analysis. 
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form of the protein that runs in the hyperphosphorylated state constitutively, a state which can be 
collapsed with λ phosphatase (Figure 22C). This constitutive hyperphosphorylation of the 
phosphatase dead mutant depends on the presence of the 6 Ser and Thr identified sites of 
phosphorylation (Figure 22C). These data suggest that Clp1p auto-dephosphorylates during 
mitotic exit, and that failure to remove Cdk1p phosphorylations mimics Clp1p 
hyperphosphorylation observed in mitotic arrested cells.  
 
Clp1p auto-dephosphorylates in vitro in trans 
We next asked whether Clp1p auto-dephosphorylates in vitro during incubation with 
Cdk1p kinase complex. Incubation of Clp1p phosphatase dead with kinase active Cdk1p yields a 
substantial increase in radiolabel incorporation retained than when wild type Clp1p acts as the 
phospho-acceptor (Figure 23A). This could result from enhanced phosphorylation of 
phosphatase dead Clp1p, or could result from Clp1p auto-phosphatase activity during the course 
of the reaction. To test the latter possibility, we again performed the kinase reactions as before 
but this time in the presence of sodium vanadate, a potent inhibitor of the tyrosine phosphatase 
superfamily. In the presence of vanadate, wild type Clp1p retained the same amount of radiolabel 
incorporation as did the phosphatase dead mutant after incubation in either the presence or 
absence of the inhibitor (Figure 23A). Thus, Clp1p auto-dephosphorylates both in vitro and in 
vivo.  
While these data argue that Clp1p has the ability to auto-dephosphorylate, they do not 
demonstrate whether this occurs in cis, in trans, or both. To determine if Clp1p has the ability to 
dephosphorylate in trans, we phosphorylated a C-terminal fragment of Clp1p lacking the 
phosphatase domain in vitro with Cdk1p. This phosphorylated fragment was then used as an in 
vitro substrate for increasing concentrations of   recombinant Clp1p and a phosphatase dead 
mutant. Whereas increasing concentrations of phosphatase active Clp1p reduced the amount of 
radiolabel incorporation, the highest concentration of phosphatase dead Clp1p failed to 
dephosphorylate this fragment (Figure 23B). To test if trans auto-dephosphorylation could also 
occur in vivo, we expressed HA-clp1+ or a HA-clp1PD phosphatase dead mutant under the control 
of the inducible nmt promoter in clp1∆, clp1+, or phosphatase dead mutant backgrounds, where 
endogenous clp1+ was tagged with the myc epitope. HA-Clp1p-PD expression led to an 
accumulation of the hyperphosphorylated species in all backgrounds tested. However, a  
Figure 23. Clp1p auto-dephosphorylates in trans in vitro. A) MBP-Clp1p or MBP-Clp1p-PD 
(Phosphatase Dead) were subjected to in vitro kinase assays with kinase active Cdk1p in the presence
or absence of 100 µΜ sodium vanadate. Reactions were resolved on SDS PAGE, Coomassie stained,
and exposed to film for autoradiography. B) GST-∆clp1p containing aa 348-537 was subjected to in 
vitro phosphorylation by kinase active Cdk1p, and then incubated in the presence of buffer alone, 
MBP-Clp1p-PD (Phosphatase Dead), or increasing concentrations of phosphatase active MBP-Clp1p.
Reactions were resolved on SDS PAGE, coomassie stained, and exposed to film for autoradiography.
C) clp1-myc (KGY 2882), clp1∆ (KGY 3381), and clp1::D257A-myc (KGY 4687-PD) strains 
transformed with pRHA:EV (EV), pRHA:clp1 (+), and pRHA:clp1-PD (PD) vectors were induced to 
express HA-Clp1p. Samples were processed for Clp1p-myc and Clp1p-HA phosphorylation status via
immunblot analysis. Arrows indicate position of different phosphorylated species. D) wild type 
(KGY 246), clp1-HA (KGY 139), clp1-myc (KGY 2882), and clp1-HA/clp1-myc (KGY 5080) cells were
grown at 32ºC overnight and lysates prepared for co-immunoprecipitation analysis. Immuoprecipitates 
were probed with 9E10 and 12CA5 to detect presence of Clp1p in the immune complex. 
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significant increase in hyperphosphorylation was seen when HA-Clp1p-PD was expressed in the 
absence of phosphatase activity in either the clp1∆ or D257A-myc strains (Figure 23C, compare 
top two arrows). Significantly, expression of HA-Clp1p led to the accumulation of the 
phosphatase dead mutant in the hypophosphorylated state, suggesting that trans auto-
dephosphorylation can also occur in vivo. We could not establish whether this dephosphorylation 
could also occur in cis. However, Clp1p does have the ability to self-associate in vivo, as analysis 
of a diploid strain in which one copy was tagged with the HA epitope and the other with the MYC 
epitope revealed that immune complexes of Clp1p-HA also specifically contained Clp1p-MYC 
(Figure 23D). Quantification of the relative amount of interaction suggests that about 10% of the 
Clp1p protein is self-associated under these experimental conditions. 
 
Mitotic Phosphorylation of Clp1p Reduces its Catalytic Activity 
Although Clp1p possesses the ability to auto-dephosphorylate, during mitosis Clp1p 
accumulates in the hyperphosphorylated state (Figure 24A). In fact, recombinant MBP-Clp1p 
incubation with mitotic Clp1p immune complexes failed to collapse the higher migrating bands 
despite the fact that λ phosphatase could do so (Figure 24A). Phosphatase assays for Cdc14p 
proteins have only been described for the two human homologs, hCdc14A and hCdc14B. The 
authors concluded from these studies that the activities varied little across the cell cycle, with 
hCdc14A being slightly more active during S phase and in late mitosis during mitotic exit 
(Kaiser et al., 2002). In order to determine if Clp1p activity may be cell cycle regulated, we 
developed a phosphatase activity assay in which immunoprecipitated material is the source of the 
phosphatase. Clp1p presence in the immune complexes as well as the active site Cys and Asp 
residues were required to hydrolyze the artificial substrate, DiFMUP (Figure 24B). Continuous 
assays performed over time revealed that Clp1p activity varied little during different interphase 
blocks (Figure 24B). The finding that Clp1p activity was essentially the same from cells arrested 
in G2 by either cdc25-22 or cdc3-124 mutations was surprising since Clp1p behaves dramatically 
differently in each of the mutants. During a G2 arrest imposed by cdc25-22, Clp1p remains 
nucleolar and at the spindle pole body (Trautmann et al., 2001; Cueille et al., 2001). This is in 
contrast to the G2 arrest achieved by activation of the cytokinesis checkpoint mutant, cdc3-124. 
During this block, Clp1p is dispersed throughout the nucleus and cytoplasm where its activity is 
required to maintain the block (Figure 25B) (Trautmann et al., 2001; Cueille et al., 2001). If  
Figure 24. Cdk1p dependent phoshorylation of Clp1p reduces its cataltyic activity. A) clp1-myc 
(KGY 2882-Asyn) cells grown at 32ºC and nda3-KM311 clp1-myc (KGY 3388) cells grown at 18ºC were 
processed for Clp1p phosphorylation status via immunblot analysis after treatment with buffer alone (BA),
MBP-Clp1p (+), MBP-D257A (PD), or λ phosphatase. B) wild type (KGY 246) (Unt), clp1-myc 
(KGY 2882-Asyn), clp1::6A-myc (KGY 4594) (6A), and clp1::C286S-myc (KGY 5018) (PD) cells grown
at 32ºC, cdc25-22 clp1-myc (KGY 3766) and cdc3-124 clp1-myc (KGY 5124) cells grown at 36ºC, and 
nda3-KM311 clp1-myc (KGY 3388) cells grown at 18ºC were processed for Clp1p phosphatase activity 
via ability to hydrolyze DiFMUP and Clp1p phosphoylation state and levels via immunoblot analysis. 
C) nda3-KM311 clp1-myc (KGY 3388) cells were arrested at prometaphase by incubation at 18ºC for 7 
hours. Cells were then released to 32ºC and samples taken at the indicated time points. Samples were 
processed for DiFMUP hydrolysis and Clp1p levels and phosphorylation state as in B). D) MBP-Clp1p 
was incubated in the presence of kinase active (KA) or kinase dead (KD) Cdk1p and ATP-γ-S at 30ºC for 
7 hours, prior to being incubated in the presence of pNPP. pNPP reactions were continued at 30ºC and 
samples removed at the indicated time points and absorbance was determined by spectrophotometric 
analysis.
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there is a nucleolar competitive inhibitor of Clp1p function analogous to Net1p/Cfi1p, the 
interaction must be lost under our lysis conditions. However, during early mitosis in cells 
arrested by the nda3-KM311 mutant, the rate at which Clp1p hydrolyzes DiFMUP is reduced by 
nearly half of that observed during interphase blocks (Figure 24B). Because Clp1p is in the 
hyperphosphorylated state during this arrest, these data suggest that mitotic phosphorylation of 
Clp1p inhibits its catalytic activity and prevents substrate dephosphorylation. To examine if 
Clp1p dephosphorylation during mitotic exit leads to a restoration of its catalytic activity, we 
performed an nda3-KM311 block and release experiment. As cells exited mitosis and underwent 
septation, Clp1p became hypophosphorylated and its catalytic activity increased as the 
phosphorylation was reversed (Figure 24C). These data suggest that Clp1p activity is inhibited 
during early mitosis, and regains its full activity coincidentally with its dephosphorylation during 
mitotic exit. We additionally tested the effects phosphorylation by Cdk1p played in vitro on 
MBP-Clp1p activity. To circumvent the issue that MBP-Clp1p auto-catalytically removes Cdk1p 
phosphorylation events, we included in the kinase reactions the non-hydrolyzable ATP analog, 
ATP-γ-S. Cdk1p uses this form of ATP less efficiently (data not shown), and therefore required 
longer incubation times to achieve a sub-stoichiometric hyperphosphorylation of Clp1p in vitro. 
After incubation with Cdk1p kinase active, MBP-Clp1p ability to hydrolyze the artificial 
substrate pNPP was reduced by nearly half that achieved upon incubation with kinase dead 
Cdk1p (Figure 24D). Fifty percent inhibition of Clp1p catalytic activity is consistent with the 
immunoprecipitation data, and both likely represent underestimates of the effect of 
phosphorylation on Clp1p activity due to a lack of stoichiometric phosphorylation under each 
assay condition. Again, these data corroborate a model whereby mitotic phosphorylation of 
Clp1p by Cdk1p reduces its catalytic activity, and then elimination of these phosphorylation 
events during mitotic exit restores its full activity. Inhibition of Clp1p activity in early mitosis is 
likely required to ensure that Clp1p substrate(s) dephosphorylation occurs only after Cdk1p 
activity drops. 
 
Clp1p Phosphosite Mutants Possess Reduced Phosphatase Activity 
We examined in more detail the non-phosphorylatable Clp1p mutants, as they would be 
predicted to be recalcitrant to Cdk1p mediated inhibition. Three methods of in vivo analysis of 
Clp1p phosphosite mutant function lead us to conclude that these mutants are not insensitive to 
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inhibition by Cdk1p, but rather are defective for Clp1p phosphatase activity even in the absence 
of phosphorylation. First, nda3-KM311 clp1-6A cells maintain the mitotic arrest and do not 
prematurely inactivate Cdk1p (Figure 22B). Second, Clp1p phosphosite mutants divide 
prematurely in a manner consistent with their in vitro phosphatase activities (Figure 25A). This 
is similar to cells deleted for clp1+. Third, Clp1p phosphosite mutants are unable, to varying 
degrees, to arrest cell division in response to activation of the cytokinesis checkpoint by the 
cdc3-124 mutation (Figure 25B). Sustained checkpoint activation requires Clp1p function, as a 
phosphatase dead mutant fails to arrest as binucleate cells (Figure 25B).  
Mutation of the 6 identified Ser and Thr sites to Asp to mimic the phosphorylated state 
resulted in a form of the protein that runs constitutively in the hyperphosphorylated state, whose 
mobility is unaffected by incubation with λ phosphatase (Figure 22C). In fact, the 
phosphomimetic mutant Clp1p-6D shows an even greater reduction in cell size at division as 
well as a reduced ability to arrest nuclear division in response to cytokinesis checkpoint 
activation (Figure 25A and 25B). Because of the similar results obtained for both the non-
phosphorylatable and phosphomimetic Clp1p mutants, we examined their in vitro phosphatase 
activities. Whereas MBP alone and MBP-Clp1p-PD failed to hydrolyze the artificial substrate 
pNPP, MBP-Clp1p hydrolyzed the chemical in a manner that was linear with respect to time 
(Figure 25C). MBP-Clp1p-6A showed reduced ability to hydrolyze pNPP with kinetics reduced 
to nearly fifty percent of the wild type phosphatase (Figure 25C). Further mutation to produce a 
Clp1p mutant lacking 8 putative Cdk1p phosphorylation sites mimicked a phosphatase dead 
Clp1p mutant in its ability to hydrolyze pNPP in vitro as well as in its ability to sustain the 
cytokinesis checkpoint (Figure 25B and 25C). Again, Clp1p-6D phosphomimetic resulted in a 
recombinant phosphatase severely impaired for pNPP hydrolysis. In fact, MBP-Clp1p-6D 
possesses nearly half the activity of the 6A mutant both in vitro and in vivo (Figure 25B and 
25D). We conclude that these phosphosite mutants of Clp1p are loss of function mutations. 
Because of the similar phenotypes of the 6A and 6D Clp1p mutations, the desired effect of 
generating mutants recalcitrant to Cdk1p mediated inhibition was not achieved.  
 
Plo1p Involvement in Clp1p Mitotic Phosphorylation 
Because recombinant Clp1p was unable to collapse the higher mobility forms of Clp1p 
isolated from nda3-KM311 arrested cells (Figure 24A), we wanted to determine if secondary  
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Figure 25. Clp1p phosphosite mutants have reduced activity in vivo and in vitro. A) clp1-myc (KGY 2882),
clp1∆ (KGY 3381), clp1::C286S-myc (KGY 5018), clp1::D257A-myc (KGY 4687), clp1::6A-myc (KGY 
4594), clp1::6D-myc (KGY 5184), and clp1::8A-myc (KGY 4807) cells were grown at 32ºC and measured
live for cell length at division. The number in parenthesis above the bars correspond to the average cell 
size at division. B) cdc3-124 clp1-myc (KGY 5124), cdc3-124 clp1∆ (KGY 655), cdc3-124 
clp1::D257A-myc (KGY 4828), cdc3-124 clp1::6A-myc (KGY 4826), cdc3-124 clp1::8A-myc (KGY 
4827), and cdc3-124 clp1::6D-myc (KGY 5366) cells were shifted to the restrictive temperature of 36ºC 
for 4 hours. Cells were fixed with ethanol and stained with DAPI to visualize nuclei. About 200 cells were
counted for each strain and scored for those containing 1 or 2 nuclei, or more than 2 nuclei. C) and D) The
indicated MBP-Clp1p mutants were incubated in the presence of pNPP at 30ºC for 30 minutes. Sample 
absorbance was determined at the indicated time points. C)The top panel represents a Coomassie stained 
SDS PAGE of the reaction inputs.  
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phosphorylation events after prior Cdk1p phosphorylation rendered the phosphatase resistant to 
auto-dephosphorylation. Such a collaborative effort of two mitotic kinases has been proposed for  
Cdk1p and the Polo family of protein kinases (Elia et al., 2003). Polo family kinases contain a 
conserved domain, the Polo Box, which is targeted to phosphoepitopes created by Cdk1p 
substrate phosphorylation at the consensus of Ser-pSer/Thr-Pro (Figure 26A) (Elia et al., 2003; 
Barr et al., 2004). In most cases, Polo kinase binding to the phosphoepitope relieves the auto-
inhibition of intramolecular bonding within the Polo Box domain and allows phosphorylation of 
the substrate at the consensus sites Glu/Asp/Gln-X-Ser/Thr-Z. Clp1p primary amino acid 
sequence contains two such Polo Box recognition motifs, one of which was identified as being 
phosphorylated in vivo (Figure 20C and Figure 26B), as well as several sequences matching the 
Polo kinase consensus. To examine if the Polo kinase family member in S. pombe, Plo1p, played 
a role in mitotic hyperphosphorylation of Clp1p, we created a mitotic checkpoint arrest through 
incubation of the nuf2-2 allele (Nabetani et al., 2001) at the restrictive temperature either in the 
presence or absence of plo1 activity. Although nuf2-2 and nuf2-2 plo1-24C both arrested cell 
division in mitosis with elevated Histone H1 kinase activity, the extent of Clp1p 
hyperphosphorylation was reduced in the nuf2-2 plo1-24C background (Figure 26C). The level 
of Histone H1 activity obtained from a nuf2-2 arrest is approximately one third that obtained 
from nda3-KM311 arrest, and as a consequence, results in a modest decrease in 
hyperphosphorylation of Clp1p. Together, these data suggest that Clp1p may be targeted by the 
Plo1p kinase for mitotic phosphorylation after prior Cdk1p phosphorylation, preventing Clp1p 
from auto-dephosphorylating at this time. It is not clear if this secondary phosphorylation results 
in an additional attenuation of Clp1p activity. However, this seems unlikely since measurements 
of Clp1p activity from mitotic arrests matched so closely those obtained after phosphorylation in 
vitro by Cdk1p. This awaits further experimentation, but Plo1p phosphorylation of Clp1p may 
act as an additional layer of control to prevent premature Clp1p disruption of Cdk1p 
phosphorylation events.  
 
 
 
 
 
Figure 26. Polo kinase involvement in Clp1p mitotic phosphorylation. A) Model of Polo kinase 
recruitment of Polo Box Domains to phosphorylated Ser/Thr with the consensus S-S/T-P where 
S = Ser, T = Thr, and P = Pro. Polo kinase binding frees the kinase domain to phosphorylate substrate
with the consensus of E/D/Q-X-S/T-Z, where E = Glu, D = Asp, Q = Gln, X = Any amino acid,
S = Ser, T = Thr, and Z = Hydrophobic amino acid. B) Clp1p primary amino acid sequence contains
two putative Polo Box Domain binding sites designated by underlining. Site T382 was identified as
being phosphorylated in vivo, whereas S483 was not identified as a phosphorylation site. C) wild 
type (KGY 246-Unt), clp1-myc (KGY 2882-Asyn), nuf2-2 clp1-myc (KGY 5364), nuf2-2 plo1-24C 
clp1-myc (KGY 5365), and nda3-KM311 clp1-myc (KGY 3388) cells arrested at the respective 
restrictive temperatures were processed for Clp1p phosphorylation status through immunoblot analysis
(upper panel) and for Histone H1 kinase activity (lower panel). Histone H1 activities were quantified 
by Cherkov counting of radioactive bands.  
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Summary 
 Although Clp1p is released from the nucleolus in early mitosis and potentially free to 
target mitotic substrates for dephosphorylation (Trautmann et al., 2001; Cueille et al., 2001), 
mitotic substrates still accumulate in the hyperphosphorylated state. Our data suggest that during 
this time Clp1p phosphatase activity is attenuated through inhibitory phosphorylations by the 
mitotic kinase, Cdk1p. We have identified mitotic specific phosphorylation events that occur at 
Cdk1p consensus sites. Cdk1p has the ability to phosphorylate these sites in vitro, and Clp1p 
auto-catalytically reverses them at the exit from mitosis. The resulting effect of this 
phosphorylation, inhibition of catalytic activity, likely acts to restrain Clp1p targeting of key 
substrates during early mitosis. This is yet one more example of Cdk1p inhibition of its negative 
regulators during early mitosis.  
We have additionally shown that phosphosite mutants of Clp1p are defective in 
phosphatase activity both in vitro and in vivo. It is currently unclear why these mutants are 
defective, but a plausible explanation is that these residues are important for structural stability 
of the phosphatase-substrate interaction. Additionally, similar to budding yeast Cdc14p, Clp1p 
oligomerization may be important for its activity (Taylor et al., 1997). Mutation or 
phosphorylation of these residues may adversely affect Clp1p oligomerization.   
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CHAPTER V 
 
DISCUSSION 
 
Summary 
 Cdc14 proteins reverse mitotic Cdk1p phosphorylation events in a variety of eukaryotes 
(reviewed by Trautmann and McCollum, 2002). In the budding yeast, S. cerevisiae, Cdc14p is 
essential to bring about complete abrogation of Cdk1p activity during exit from mitosis (Visintin 
et al., 1998). This study has shown that the Cdc14 family member, S. pombe Clp1p, is not 
essential for mitotic exit, but instead coordinates attenuation of Cdk1p activity with SIN 
signaling to facilitate proper genomic inheritance of the progeny. clp1∆ mutants delay mitotic 
exit due in part to a failure to disrupt the Cdk1p auto-amplification loop that drives mitotic 
progression. Clp1p dephosphorylates and inactivates Cdc25p during the exit from mitosis and 
targets the phosphatase for proteolysis. These events are required for the coordination between 
exit from mitosis and entry into the subsequent cycle. Clp1p mediated disruption of the Cdk1p 
auto-amplification loop is temporally regulated to occur only after the onset of anaphase and the 
initiation of mitotic kinase inactivation in S. pombe (Figure 27). The mechanism whereby this 
occurs involves a positive feedback loop of Clp1p phosphatase activity. Cdk1p mediated 
phosphorylation of Clp1p during early mitosis attenuates its catalytic activity. Full activity is 
restored upon the exit from mitosis as Clp1p auto-dephosphorylates and is free to target its 
substrates for dephosphorylation. Hence, self-sustaining regulation of both Cdk1p and Clp1p 
drive mitotic progression and exit in S. pombe.   
 
Cdc14 mediated inhibition of Cdk1p 
 Cdc14p in S. cerevisiae dephosphorylates several key substrates to achieve complete 
abrogation of Cdk1p activity, which occurs through stabilization of a Cdk1p inhibitor (Sic1p) 
and destruction of mitotic B-type cyclins (Visintin et al., 1998). Mitotic Cdk1p inactivation 
occurs in two successive waves due to the need for budding yeast to delay complete Cdk1p 
inactivation until the mitotic spindle has elongated through the bud neck. The first phase requires 
the activities of the APCCdc20 at the metaphase to anaphase transition, while the second phase 
requires the APCCdh1/Hct1 at mitotic exit (Yeong et al., 2000). S. cerevisiae Cdc14p is required for  
Figure 27. Model for Cdk1p inhibition through Clp1p activation. During mitosis, Clp1p activity is
attenuated due to the presence of mitotic phosphorylations. As a consequence, Cdk1p activity remains
very high. At this time, Clp1p activity targets the passenger protein complex to promote its 
kinetochore localization. As Cdk1p activity diminishes due to some cyclin B degradation, Clp1p auto-
dephosphorylates, and is then free to dephosphorylate Cdc25p and Wee1p to further inactivate Cdk1p
by promoting its Tyr-15 phosphorylation. Note that the forward reaction is always the favored state.
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activation of the latter APC complex through dephosphorylation of Cdh1p/Hct1p, and therefore 
controls the complete attenuation of Cdk1p at mitotic exit (Visintin et al., 1998; Jaspersen et al., 
1999). hCdc14A also possesses the ability to activate the APCCdh1/Hct1 in reconstituted 
preparations through dephosphorylation of hCdh1p (Bembenek and Yu, 2001). However, it 
remains unclear whether all Cdc14 family members will prove to regulate mitotic exit and if so, 
whether this occurs through APC/C activation. In fact, Cdc14 family members are not essential 
for mitotic exit in many eukaryotes examined, but instead are required to regulate cytokinesis 
and the centrosome cycle (Kaiser et al., 2002; Mailand et al., 2002a; Kaiser et al., 2004; 
Gruneberg et al., 2002; Trautmann et al., 2001; Cueille et al., 2001). This work and that of others 
have shown that S. pombe cells lacking the Clp1p phosphatase display only a delay in exit from 
mitosis, and seem to regulate the inactivation of Cdk1p dramatically different from S. cerevisiae 
Cdc14p (Cueille et al., 2001; Wolfe and Gould, 2004; Esteban et al., 2004).  
 Our data indicate that Clp1p reverses Cdk1p dependent phosphorylation events present 
on Cdc25p at mitotic exit, resulting in its inactivation. These dephosphorylation events play a 
key role in disrupting the Cdk1p auto-amplification loop and attenuating Cdk1p activity in late 
mitosis. Our data further suggest that these phosphorylation events are necessary for a timely 
progression through mitosis, as their elimination reduces Cdc25p ability to promote mitotic 
entry. Cdc25 proteins from other eukaryotes are similarly hyperphosphorylated during mitosis, 
and these events have been predicted to affect the timing of mitotic entry (Hoffmann et al., 1993; 
Izumi and Maller, 1993). In the case of SpCdc25, XCdc25, and hCdc25C, this mitotic 
phosphorylation is dependent upon Cdk1p activity and stimulates its catalytic activity 
(Kovelman and Russell, 1996; Izumi and Maller, 1993; Hoffmann et al., 1993). As the 
hyperphosphorylation of Cdc25 homologs represents a conserved element of mitotic control, it 
will be interesting in the future to determine if their inactivation by Cdc14 homologs is also 
conserved. 
 In a mechanism unrelated to the dephosphorylation events, Clp1p also targets Cdc25p for 
ubiquitin-mediated proteolysis during the exit from mitosis. Previous data has implicated the 
HECT-domain containing ubiquitin ligase, Pub1p, in the in vivo ubiquitination of Cdc25p 
(Nefsky and Beach, 1996). However, this study did not address the temporal aspect of Cdc25p 
destabilization. We have demonstrated that Cdc25p late mitotic turnover does not require Pub1p, 
but instead, requires the function of Clp1p in addition to the APC/C ubiquitin ligase. The N-
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terminal regulatory domain of Cdc25p contains intrinsic elements capable of promoting its 
instability. This same region contains 3 putative destruction boxes and is sufficient for Clp1p 
binding. It is not clear at this time whether stabilization of Cdc25p truncated at the N-terminus 
results from the lack of signals present or from a lack of Clp1p binding. Again, Cdc25 turnover 
by APC/C represents a conserved feature of its regulation. hCdc25A is a target of the APC/C in 
late mitosis following the removal of Cdk1p sites of phosphorylation (Mailand et al., 2002b). 
Whether or not one of the human Cdc14 homologs initiates proteolysis of hCdc25A through its 
dephosphorylation has not been determined. In S. pombe, Clp1p plays a more active role in 
Cdc25p proteolysis than merely reversal of Cdk1p phosphorylation events, as elimination of sites 
of phosphorylation does not lead to its rapid turnover in G1 in the absence of Clp1p function. The 
exact mechanism of how Clp1p functions with the APC/C to regulate stability of Cdc25p 
remains obscure. We speculate that this could involve Clp1p activation of the APC/C or involve 
its role as an accessory factor for Cdc25p destruction. 
 Exit from mitosis is also coincident with the binding of Cdc25p to 14-3-3 proteins and its 
subsequent nuclear exclusion in S. pombe (Lopez-Girona et al., 1999). Phosphorylation of 
Cdc25p by response site kinases promotes its affinity for 14-3-3 molecules (Zeng and Piwnica-
Worms, 1999; Lopez-Aviles et al., 2005). In Xenopus Cdc25 and hCdc25C, Cdk1p 
phosphorylation at the -2 site relative to the response site interferes with response site 
phosphorylation (Bulavin et al., 2003). A similar mechanism may be operating within S. pombe 
Cdc25p in which mitotic phosphorylation events drive nuclear accumulation of Cdc25p by 
precluding response site phosphorylation. This model suggests that the resumption of Cdc25p 
and 14-3-3 binding could only occur after reversal of the mitotic Cdk1p phosphorylation events 
by Clp1p. Consistent with this notion, we have found an increased ability to detect Cdc25p in 
late mitotic nuclei in the absence of Clp1p. Whether this results from the increased abundance of 
Cdc25p in clp1∆ cells or from Clp1p regulating rates of Cdc25p nuclear export through 14-3-3 
binding has not been determined. This model also suggests that a late mitotic response site kinase 
would play similar inhibitory roles to both Cdc25p function and Cdk1p activity. In S. pombe, the 
checkpoint kinases Chk1p and Cds1p phosphorylate the response sites in Cdc25p upon 
checkpoint activation (Zeng et al., 1998; Zeng and Piwnica-Worms, 1999; Furnari et al., 1999). 
Additionally, these sites are phosphorylated during G2 by the stress-activated kinase, Srk1p, in 
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the absence of checkpoint signaling (Lopez-Aviles et al., 2005). Thus, one or more of these 
kinases may collaborate with Clp1p to remove remaining nuclear Cdc25p. 
 Our results suggest that Clp1p functions in late mitosis to combat Cdk1p activity by 
disrupting the Cdk1p auto-amplification loop. Activation of Cdc25 family members and 
inactivation of the Wee1 and Myt1 family of kinases at the G2/M transition by Cdk1p drives 
mitotic initiation in a switch-like fashion (reviewed by O'Farrell, 2001). Our data suggest that 
disruption of this amplification loop is an active mechanism whereby Cdc14 phosphatases aid in 
Cdk1p inactivation. S. cerevisiae rely on full destruction of mitotic cyclins and accumulation of a 
Cdk1p inhibitor (Sic1p) for abrogation of Cdk1p activity (Visintin et al., 1998). Because full 
Cdc13p (Cyclin B) destruction is never observed in late mitosis of wild type S. pombe cells 
(Chang et al., 2001), and the Cdk1p inhibitor Rum1p plays no obvious roles in Cdk1p 
inactivation (Blanco et al., 2000), S. pombe cells may utilize Tyr-15 phosphorylation of Cdk1p as 
a mechanism to further inactivate Cdk1p. Evidence from S. cerevisiae points to the fact that in 
times of prolonged spindle checkpoint activation, cells can adapt and inactivate Cdk1p through 
inhibitory phosphorylation, as occurs in cdc55Δ mutants (Minshull et al., 1996). Bypass of this 
arrest does not affect proteolysis of the cyclin B, Clb2p, but instead relies on Tyr-19 
phosphorylation to inhibit Cdk1p activity (Minshull et al., 1996).  
There are two plausible mechanisms that could account for the disruption of the Cdk1p 
positive feedback loop in late mitosis. Downregulation of Cdk1p through degradation of small 
pools of cyclin B could reduce Cdk1p activity to levels such that more cyclin B is targeted for 
degradation. Disruption of the positive feedback loop would therefore occur passively as the 
amount of Cdk1p activity required to sustain it would be eliminated. Second, active disruption of 
the positive feedback loop through activation of specific phosphatase(s) could reduce Cdk1p 
activity to levels that are competent to stimulate APC/C activity. This would subsequently lead 
to more cyclin B destruction and a concomitant drop in kinase activity. Our evidence suggests 
that disruption of the positive feedback loop stems from a combination of the two possibilities. 
While elimination of the amplification loop most likely does not act as a trigger for Cdk1p 
inactivation, disruption of it is an active process, requiring the Clp1p phosphatase in S. pombe. 
We speculate that the concerted efforts of protein phosphatases (i.e. Cdc14 family members) 
working with response site kinases, together with the APC/C, play important roles in shutting off 
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this amplification loop. It will be important in the future to determine the temporal order of such 
late mitotic events that catalyze the abrogation of Cdk1p activity. 
This model also suggests that the inhibitory Thr-14/Tyr-15 kinases (Wee1 and Myt1) are 
similarly dephosphorylated and activated during late mitosis to aid in the inactivation of Cdk1p. 
Wee1 proteins in Xenopus and human cells are inactivated through phosphorylation in mitosis, 
possibly due to the concerted efforts of Cdk1p and Polo kinases (Mueller et al., 1995a; Watanabe 
et al., 2004). Although it is not clear if Wee1 proteins are re-activated by dephosphorylation in 
late mitosis, S. cerevisiae Swe1p is transiently dephosphorylated during the exit from mitosis, 
just prior to its degradation and degradation of the major cyclin B, Clb2 (Harvey and Kellogg, 
2003). While activity assays have not been reported for Swe1p, its mitotic hyperphosphorylation 
may inhibit its catalytic activity. Therefore it is possible that the dephosphorylated form of 
Swe1p in late mitosis plays a role in inactivating Cdk1p. Should this be the case, then the feed-
forward amplification loop which rapidly stimulates activation of Cdk1p at mitotic onset, 
additionally provides a rapid switch to inactivate mitotic Cdk1p at mitotic exit.  
 
Clp1p Mitotic Phosphorylation - Analogous to FEAR? 
 Whereas Clp1p is released from the nucleolus in early mitosis (Trautmann et al., 2001; 
Cueille et al., 2001), its ability to target Cdk1p mitotic substrates for dephosphorylation is 
limited. We have shown that mitotic phosphorylation of Clp1p by Cdk1p attenuates its catalytic 
activity during early mitosis. Clp1p auto-catalytically reverses these phosphorylation events at 
mitotic exit. This not only provides a switch-like activation of Clp1p in late mitosis, but also a 
mechanism to prevent reversal of mitotic Cdk1p phosphorylation events prior to sister chromatid 
separation when Cdk1p activity is maximal. We propose that full Clp1p activation may occur in 
two steps. The first occurs upon release from the nucleolus as cells enter mitosis when Clp1p 
becomes concentrated at the contractile ring and at the kinetochore (Trautmann et al., 2001; 
Cueille et al., 2001; Trautmann et al., 2004). Although its activity is attenuated due to mitotic 
phosphorylation, Clp1p activity is required at the kinetochore for monitoring chromosome bi-
orientation (Trautmann et al., 2004). The second step involves autocatalytic reversal of these 
inhibitory phosphorylation events at mitotic exit, resulting in full Clp1p activation. During this 
phase, Clp1p is able to target Cdc25p for dephosphorylation and disrupt the Cdk1p auto-
amplification loop. 
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 The regulation of Clp1p in S. pombe resembles the stepwise activation of S. cerevisiae 
Cdc14p. The FEAR and MEN networks collaborate to promote the full release of Cdc14p from 
its nucleolar inhibitor (reviewed by Stegmeier and Amon, 2004). Whereas the FEAR network 
causes the early anaphase release of Cdc14p, the MEN promotes full activation and release of 
Cdc14p during the exit from mitosis (Pereira et al., 2002; Stegmeier et al., 2002; Shou et al., 
1999; Visintin et al., 1999). Upon release from Net1p/Cfi1p by the FEAR, Cdc14 targets 
substrates involved in a number of mitotic processes. Cdc14p aids stability of the anaphase B 
spindle through dephosphorylation of the INCENP-Aurora-Survivin passenger protein complex 
and other MAPs that localize to the spindle midzone (Higuchi and Uhlmann, 2005; Pereira and 
Schiebel, 2003). Cdc14p also enters into a positive feedback loop for MEN activation as it 
dephosphorylates and activates the effector kinase Cdc15p (Stegmeier et al., 2002). Strikingly, 
FEAR released Cdc14p also interacts with the MEN GAP component, Bfa1p, but fails to 
dephosphorylate it until the exit from mitosis (Pereira et al., 2002). These data suggest that while 
Cdc14 may be targeted to distinct substrates by the FEAR, an additional layer of specificity 
controlling the temporal order of substrate dephosphorylation remains that we do not yet 
understand.  
 The preference of Cdc14p to target only a subset of its substrates during early anaphase 
raises the intriguing question of how selectivity is achieved. Why are some substrates 
preferentially targeted prior to others? The involvement of a single Cdk1p capable of driving 
both the budding and fission yeast cell cycles also raises the same important question. As for 
Cdk1p, it is thought that both substrate accessibility and the requirement of distinct substrates for 
varying levels of Cdk1p activity guide the temporal regulation of substrate phosphorylation 
(Hayles et al., 1994; Loog and Morgan, 2005). The same argument could be made for FEAR 
released Cdc14p: its access to some substrates is either limited by accessibility or requires a 
higher degree of Cdc14p activity that only becomes present upon MEN activation.  
 Most likely, both mechanisms operate to control Cdc14p substrate dephosphorylation. 
FEAR released Cdc14p is distributed throughout the nucleus, and concentrates at the spindle 
pole body, the mitotic spindle, and at the kinetochores, but fails to localize to the cytoplasm 
(Pereira et al., 2002; Stegmeier et al., 2002; Yoshida et al., 2002). This localization pattern 
precludes its ability to dephosphorylate the Sic1p transcription factor, Swi5p, which resides in 
the cytoplasm when phosphorylated by Cdk1p (Moll et al., 1991). Thus, Cdc14p fails to 
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inactivate Cdk1p through Sic1p accumulation during early anaphase. With regard to Bfa1p, 
Cdc14p overexpression in metaphase-arrested cells is capable of driving its dephosphorylation 
(Pereira et al., 2002). Yet, despite their interaction at the spindle pole body during early 
anaphase, Cdc14p does not dephosphorylate Bfa1p until after MEN activation (Pereira et al., 
2002). This suggests that perhaps MEN activation, or Cdk1p inactivation, aids Cdc14p-mediated 
Bfa1p dephosphorylation. 
 One key function of Clp1p prior to anaphase occurs at the kinetochore and involves the 
maintenance of the INCENP-Aurora-Survivin complex at these sites to monitor chromosome bi-
orientation (Trautmann et al., 2004). clp1∆ mutants display frequent sister chromatid segregation 
defects and high rates of minichromosome loss (Trautmann et al., 2004). Clp1p phosphatase 
activity is presumably required at the kinetochore at this time as a phosphatase dead mutant 
shows similar levels of minichromosome loss as the clp1∆ mutant (Trautmann et al., 2004). 
Clp1p likely targets one or more of these passenger proteins for dephosphorylation in the 
presence of elevated Cdk1p activity prior to the initiation of anaphase. Similar to Cdc14p 
dephosphorylation of FEAR substrates, Clp1p could require a lower level of activity to target the 
passenger protein complex. It is additionally possible that because Clp1p is not 
stoichiometrically phosphorylated, that the fraction of Clp1p localized to the kinetochore is not 
inhibited through phosphorylation. Determining the key substrates in this complex that are 
targeted by Clp1p and analysis of their relative affinities for Clp1p should also distinguish 
between substrate specificity and requirements for varying levels of Clp1p activity. Whatever the 
mechanism involved, we propose that similar to budding yeast Cdc14p, S. pombe Clp1p 
activation involves a two-step process, one in which only a subset of Clp1p targets are 
dephosphorylated when Cdk1p activity remains high, followed by one in which Cdk1p activity is 
attenuated and Clp1p is free to dephosphorylate the remainder of its substrates. As hCdc14A and 
XCdc14 are similarly hyperphosphorylated during early mitosis, this may represent a conserved 
mechanism whereby Cdc14 protein substrate selectivity is temporally determined (Kaiser et al., 
2002; Kaiser et al., 2004).  
Cdk1p ensures that its activity is not prematurely attenuated prior to anaphase initiation 
by inhibiting the activities of its negative regulators. In the absence of such a mechanism, 
precocious mitotic exit and cytokinesis could occur in the absence of sister chromatid 
segregation, leading to incomplete genome inheritance of the resulting progeny. This mechanism 
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of inhibition is a conserved feature of mitotic control. The Cdk1p inhibitor Sic1p in budding 
yeast acts as a Cdk1p sensor, responding to a threshold level of Cdk1p activity. While 
phosphorylation by Cdk1p at multiple sites leads to rapid Sic1p turnover, a reduction in Cdk1p 
activity during the exit from mitosis prevents its phosphorylation, and as a consequence Sic1p 
accumulates (Nash et al., 2001). Whether or not all Cdk1p inhibitors respond to a threshold level 
of Cdk1p activity has not been determined. However, our data suggest that Clp1p may also 
respond differently to varying levels of Cdk1p activity. Clp1p phosphatase activity is inhibited 
when Cdk1p activity is maximal, and Clp1p only regains its full strength as it auto-
dephosphorylates upon Cdk1p attenuation. Thus, the removal of Cdk1p mediated inhibition from 
its negative regulators is likely to play key roles in stimulating mitotic exit in eukaryotes.   
 
Future Directions 
 We have shown that the Cdc14p family member, S. pombe Clp1p, disrupts the Cdk1p 
auto-amplification loop during the exit from mitosis, thereby attenuating Cdk1p activity. We 
have additionally shown that the cessation of the feedback loop is temporally regulated to only 
occur after sister chromatid separation, once Cdk1p activity begins to diminish. Many questions 
remain as to how these events are achieved in a coordinated manner to couple Cdk1p 
inactivation with other late mitotic events.  
 While these data have demonstrated that disruption of the Cdk1p auto-amplification loop 
in late mitosis through Cdc25p inactivation plays an important role in Clp1p-mediated Cdk1p 
activity attenuation, they also implicate an activation of the Wee1p inhibitory kinase for Cdk1p-
mediated inhibition. Esteban, et al reported that Wee1p is not regulated by the Clp1p/Flp1p 
phosphatase during mitotic exit and suggested that perhaps Cdk1p feedback loop inactivation 
involved the related Mik1p kinase (Esteban et al., 2004). Mik1p primarily is thought to function 
during S phase (Christensen et al., 2000), and its involvement in the Cdk1p auto-amplification 
loop has not been reported. The activities of Wee1p homologs in a variety of eukaryotes are 
attenuated upon mitotic entry due to phosphorylation. S. cerevisiae Swe1p is 
hyperphosphorylated in mitosis, which abolishes its ability to delay mitotic progression. The 
kinetics of Swe1p phosphorylation and dephosphorylation have been monitored in detail and 
involve several mitotic specific hyperphosphorylation events (Harvey and Kellogg, 2003). 
Strikingly, Swe1p becomes hypophosphorylated during the exit from mitosis, just prior to 
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cytokinesis (Harvey and Kellogg, 2003). Whether this hypophosphorylated state requires the 
activity of Cdc14p has not been determined. In vitro, S. pombe Wee1p is an excellent substrate 
for Cdk1p (our unpublished observations). We have also determined that Clp1p and Wee1p 
interact using a yeast-2 hybrid assay, requiring the presence of the Wee1p N-terminus (our 
unpublished observations). It will be interesting to determine whether Clp1p targets Wee1p for 
dephosphorylation at the end of mitosis, and whether this dephosphorylation leads to its 
activation. Immunoprecipitation kinase assays of Wee1p in the presence or absence of clp1+ 
from cells synchronously exiting mitosis will be used to determine the effect of Clp1p on 
functional Wee1p activity in late mitosis.  
 This work additionally shows a potential involvement by the polo family of kinases in 
Clp1p mitotic phosphorylation. Activation of polo kinases upon Polo Box recruitment to Cdk1p 
sites of phosphorylation is quickly becoming the rule rather than the exception (Elia et al., 2003; 
Watanabe et al., 2004). This collaboration between Cdk1p and Polo family kinases may be 
operating within S. pombe Clp1p. Secondary phosphorylation events at non-Cdk1p consensus 
sites may preclude Clp1p’s ability to auto-dephosphorylate or further debilitate its activity. 
Because Clp1p in vitro phosphatase activity subsequent to Cdk1p phosphorylation was nearly 
identical to that obtained from immunoprecipitates of mitotic cells, it seems unlikely that Plo1p 
phosphorylation of Clp1p would additionally attenuate its catalytic activity. However, we need to 
examine whether or not Plo1p phosphorylates Clp1p, whether this requires prior phosphorylation 
by Cdk1p, and whether this precludes Clp1p from auto-catalytically removing these 
phosphorylation events. If Plo1p phosphorylation of Clp1p does prevent Clp1p auto-phosphatase 
activity, this would suggest then that an activating phosphatase is required to dephosphorylate 
Clp1p prior to Clp1p reversing the Cdk1p phosphorylation events. We would then expect that in 
its absence, Clp1p would remain in the hyperphosphorylated state as cells exit mitosis. As a 
consequence, mutation of this phosphatase would yield similar mitotic exit defects displayed by 
a clp1∆ mutant, and Cdk1p substrates should remain in the hyperphosphorylated state. In the 
event that these predictions of Plo1p phosphorylation of Clp1p are correct, we will take a 
candidate approach to identify potential phosphatase(s) involved in reversing these Plo1p 
phosphorylation events.  
 Our data also suggest a differential requirement of various substrates for Clp1p activity. 
In early mitosis, when Clp1p is in the hyperphosphorylated state, it presumably targets the 
 76 
passenger protein complex (INCENP-Aurora-Survivin) for dephosphorylation (Trautmann et al., 
2004). However, other Clp1p substrates (Cdc25p, itself) accumulate in the hyperphosphorylated 
state at this time. These data suggest that lower amounts of Clp1p phosphatase activity are 
sufficient to target some substrates, but not others, for dephosphorylation. Because we lack 
evidence that the Clp1p fraction localized to the kinetochore is hyperphosphorylated, we will 
generate phosphospecific antibodies to mitotic Clp1p phosphorylation sites and, using indirect 
immunofluorescence, determine whether the kinetochore Clp1p fraction is phosphorylated. If 
there is a different level of activity required by some substrates, then we will determine the 
mechanism of how this selectivity is achieved. We will determine the relative Clp1p binding 
affinities and specificities for early versus late substrates in order to understand Clp1p temporal 
selectivity. 
While our data suggest that Cdk1p mediated mitotic phosphorylation of Clp1p inhibits its 
ability to dephosphorylate its substrates, we do not understand the mechanism of how this 
inhibition is achieved. We plan to use kinetic analysis comparing hyper versus 
hypophosphorylated Clp1p to understand whether phosphorylation inhibits Clp1p ability to bind 
or dissociate substrate. Our work has demonstrated that Clp1p has the ability to self-associate in 
vivo. Because this study was not performed in the absence of other S. pombe proteins, we do not 
know whether this is indicative of an oligomeric association. This merits further examination 
because recombinant ScCdc14p forms oligomers that constitute the active fraction (Taylor et al., 
1997), and XCdc14 runs as a multimer on gel filtration analysis (Kaiser et al., 2004). Clp1p 
oligomerization may be required for functional activity in vivo, and this may vary across the cell 
cycle. Co-immunoprecipitation studies from synchronous samples will be used to determine 
whether this self-association varies across the cell cycle. Analysis of the Clp1p phosphosite 
mutants demonstrated that they possessed reduced activity both in vitro and in vivo. We will 
determine whether this reduced activity stems from an altered pattern of oligomerization by 
using a bacterial dual expression system to co-express Clp1p and associated phosphosite mutants 
with different affinity tags. This should allow us to determine whether Clp1p forms oligomers, 
whether phosphorylation by Cdk1p influences this ability, and whether the phosphosite mutants 
are varied in their abilities to oligomerize. 
 Along with the effect of Cdk1p phosphorylation, we would also like to determine 
whether Clp1p responds to a threshold of Cdk1p activity, similar to the mechanism of Sic1p 
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turnover from S. cerevisiae (Nash et al., 2001). By adding back sites to the phosphosite mutants 
of Clp1p, we will be able to address whether increasing phosphorylation events leads to a 
concomitant attenuation of Clp1p activity. By equipping a sensor for Cdk1p activity within its 
negative regulators, mitotic exit can be delayed until Cdk1p activity is attenuated. Addressing 
these key questions should increase our ability to describe the ordered progression of late mitotic 
events that culminate in Cdk1p inactivation and a cycle reset.  
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CHAPTER VI 
 
CONCLUDING REMARKS 
 
 The recent years have shed increasing light as to how the events at the G2/M transition 
and mitotic exit are regulated. Mitotic initiation is driven by activation of the Cdk1-cyclin B 
complex, and its inactivation, as well as a reversal of its mitotic phosphorylation events, is 
required for a timely exit from mitosis and the initiation of cytokinesis. In S. cerevisiae, the 
conserved Cdc14p family phosphatase regulates the inactivation of Cdk1p during the exit from 
mitosis by promoting the ubiquitin-mediated proteolysis of cyclin B, and the stabilization of a 
Cdk1p inhibitor.  
Our studies into the mechanism of how the Cdc14 family member, S. pombe Clp1p, 
inhibits Cdk1p suggest that all Cdc14 family members may not regulate Cdk1p in the same 
manner as does ScCdc14p. Our data suggest that Clp1p promotes a resumption of Tyr-15 
phosphorylation of Cdk1p in late mitosis by eradicating the Cdk1p positive amplification loop 
through Cdc25p inactivation (and most likely, Wee1p activation). Furthermore, our data support 
a model in which Clp1p activity in early mitosis is attenuated by, and responsive to, elevations in 
Cdk1p activity. We hypothesize that this inhibition is required to prevent premature mitotic 
Cdk1p inactivation prior to anaphase, and this inhibition represents a conserved feature of the 
regulation of different Cdc14 family members. In conclusion, our studies have underscored the 
importance of communication between positive and negative regulators of mitotic progression to 
ensure the fidelity of the cell division process. 
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